WO2009070447A1 - Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment - Google Patents
Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment Download PDFInfo
- Publication number
- WO2009070447A1 WO2009070447A1 PCT/US2008/083248 US2008083248W WO2009070447A1 WO 2009070447 A1 WO2009070447 A1 WO 2009070447A1 US 2008083248 W US2008083248 W US 2008083248W WO 2009070447 A1 WO2009070447 A1 WO 2009070447A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- region
- coating
- retainers
- therapeutic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/856—Single tubular stent with a side portal passage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
- A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
Definitions
- this invention relates to implantable medical devices, their manufacture, and methods of use. Some embodiments are directed to delivery systems, such as catheter systems of all types, which are utilized in the delivery of such devices.
- a stent is a medical device introduced to a body lumen and is well known in the art.
- a stent is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e. by so-called “minimally invasive techniques” in which the stent in a radially reduced configuration, optionally restrained in a radially compressed configuration by a sheath and/or catheter, is delivered by a stent delivery system or "introducer" to the site where it is required.
- the introducer may enter the body from an access location outside the body, such as through the patient's skin, or by a "cut down" technique in which the entry blood vessel is exposed by minor surgical means.
- Stents, grafts, stent-grafts, vena cava filters, expandable frameworks, and similar implantable medical devices, collectively referred to hereinafter as stents, are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously.
- Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, fallopian tubes, coronary vessels, secondary vessels, etc.
- Stents may be self-expanding, expanded by an internal radial force, such as when mounted on a balloon, or a combination of self-expanding and balloon expandable (hybrid expandable).
- Stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids.
- a bifurcation is an area of the vasculature or other portion of the body where a first (or parent) vessel is bifurcated into two or more branch vessels. Where a stenotic lesion or lesions form at such a bifurcation, the lesion(s) can affect only one of the vessels
- stenoses at bifurcations can be classified based on the location of the stenoses relative to the bifurcation, as is done in the ICPS Plaque Distribution Classification and the Duke Plaque Distribution Classification.
- Many prior art stents however are not wholly satisfactory for use where the site of desired application of the stent is juxtaposed or extends across a bifurcation in an artery or vein such, for example, as the bifurcation in the mammalian aortic artery into the common iliac arteries.
- the invention is directed to a stent that elutes different volumes of at least one therapeutic agent from different regions of the stent.
- a region of the stent elutes a therapeutic agent with a different concentration than a therapeutic agent eluted from at least one other region of the stent.
- a region of the stent elutes a therapeutic agent at a different rate than at least one other region of the stent.
- FIG. 1 is a perspective view of a stent comprising a plurality of members.
- FIG. 2 is an enlarged view of one of the plurality of members of FIG. 1.
- FIG. 3 is a flat view of a bifurcated stent comprising a plurality of members and coating retainers.
- FIG. 4 is a flat view of a bifurcated stent with regions that elute different volumes of therapeutic agent.
- FIG. 5 is a flat view of another bifurcated stent with regions that elute different volumes of therapeutic agent.
- FIG. 6 is a flat view of another bifurcated stent with regions that elute different volumes of therapeutic agent.
- FIG. 7 is a side view of a bifurcated stent in an expanded state, with the side branch at an oblique angle to the main body of the stent.
- Figures 1 and 3 depict a stent 10 comprising a plurality of members 14 that form circumferential rings 11 that extend about the circumference of the stent 10.
- the stent 10 illustrated in Fig. 1 is an example of a configuration for a non-bifurcated stent 10 and the stent 10 in Fig. 3 is an example of a configuration for a bifurcated stent 10.
- the stent 10 configurations in Figs. 1 and 3 are presented as non-limiting examples of stent 10 configurations that can be used to deliver therapeutic regimens, it is within the scope of the invention for any stent 10 configuration to be used.
- Members 14, as used in this application, include both struts 13 and connectors 12.
- the struts 13 have substantially the same width and substantially the same thickness along the length of the strut 13.
- the struts 13 have substantially the same thickness along the length of the strut 13.
- the struts 13 have substantially the same width along the length of the strut 13.
- the connectors 12 have substantially the same width and substantially the same thickness along the length of the connector 12.
- the connectors 12 have substantially the same width along the length of the connector 12.
- the connectors 12 have substantially the same thickness along the length of the connector 12.
- the width of the member 14 is the distance between one circumferential side of the member 14 to the other circumferential side of the member 14.
- the thickness of the member 14 is the distance from the luminal surface of the member 14 to the abluminal surface of the member 14.
- the length of the member 14 that is straight is the distance from the proximal end of the member 14 to the distal end of the member 14.
- the length of the member 14 that is not straight is the distance of the pathway from the proximal end of the member 14 to the distal end of the member 14
- the members 14 have at least one straight section 16 and at least one turn 18, as shown for example, in Fig. 2.
- the straight section 16 of the member 14 may be the same width as the at least one turn 18, as shown for example in Fig. 1, or may be wider than the at least one turn 18, as shown for example in Fig. 3.
- Each member 14 has four sides from which therapeutic agents can be eluted: the abluminal side (side of member 14 adjacent to the lumen wall), the luminal side (side of member 14 adjacent to the lumen) and the other two sides of the member 14 which are at an oblique angle to the luminal and abluminal sides of the member 14.
- an oblique angle is any angle between 0 and 180 degrees and includes 90 degrees.
- Each member 14 has a length (L 1 ), a width (W 1 ) and a depth (not shown in Fig. 2).
- Stents 10 have different regions and/or subregions.
- the stent 10 in Fig. 1 can be divided into a proximal region 2, a middle region 4 and a distal region 6, where each region has two circumferential rings 11 of members 14.
- a stent 10 it is within the scope of the invention for a stent 10 to have one, two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen, seventeen, eighteen, nineteen, twenty or more regions.
- a bifurcated stent 10 has several regions. These regions include for example, a proximal main branch region 80a, a middle region 82 and a distal main branch region 80b, as illustrated in Fig. 3.
- the proximal main branch region 80a and the distal main branch region 80b each comprise at least one circumferential ring 11.
- the middle region 82 comprises a side branch 84 and a contralateral region 86.
- the circumferential rings l ib of the contralateral region 86 extend from a first side 92 of the side branch 84 about the circumference of the stent 10 to the second side 94 of the side branch 84.
- the side branch 84 has at least one side branch member 14 and a perimeter member 88 that defines the opening for the expandable side branch 84.
- the members 14 of the side branch 84 are a non-limiting example of a subregion of the side branch 84 region of the stent 10.
- the perimeter member 88 can have any shape, including, but not limited to, an oval, circular or rectangular shape.
- the perimeter member 88 can be a separate and distinct member 14 from the other members 14 of the stent 10 or the perimeter member 88 can be formed by some of the members 14 of the stent 10.
- the invention is directed to a stent 10 that elutes multiple therapeutic regimens from different regions and/or subregions of the stent 10.
- the stent 10 has any mechanism designed to deliver at least one therapeutic agent, including prior art means for delivering therapeutic agents, coating retainers 22, or any combination thereof.
- coating retainers 22 are discussed in greater detail in Stent Design Allowing Extended Release of Drug and/or
- coating retainers 22 can have different configurations but elute the same volume of therapeutic agent or the same configuration can be in different sizes that elute different volumes of therapeutic agent.
- coating retainer 22 refers to any mechanism designed to deliver at least one therapeutic agent that is either formed (partially or completely) within the body of the members 14 of the stent 10 or engaged to the body of the members 14 of the stent 10.
- the coating retainers 22 are positioned on at least one side of the members 14 comprising the different regions and/or subregions of the stent 10.
- Pressure differentials are one reason to configure a stent 10 to deliver multiple therapeutic regimens from different regions since differences in pressure could alter the reactivity of the therapeutic agent.
- it can be advantageous to appropriately vary the relative types, concentrations, volumes or elution rate of a therapeutic agent on different regions of the stent 10.
- a bifurcated stent 10 it can be advantageous to have different types, concentrations, volumes or elution rate in the main branch region 80 as compared to the side branch region 84, as discussed in greater detail below.
- Another reason to use a stent 10 that can deliver multiple therapeutic regimens is to target the therapies to the regions of the stent 10 that are in contact with the sites of the body lumen that requires the therapies.
- the stent 10 can be designed so that only the region of the stent 10 in contact with a stenosis would deliver/elute a therapeutic agent to treat the stenosis.
- at least one region of the stent 10 delivers a different therapeutic regimen than at least one other region of the stent 10.
- a single stent 10 delivers at least two therapeutic regimens.
- each region of the stent 10 delivers a different therapeutic regimen.
- Different therapeutic regimens include, but are not limited to, different therapeutic agents, different concentrations of therapeutic agent, different local concentrations of therapeutic agent, different volumes of therapeutic agent, different elution rates of therapeutic agent/different durations of release of therapeutic agent, different release kinetics of therapeutic agent and any combination thereof.
- the different therapeutic regimens can be used singly or in combination with one or more of the different regions of the stent 10.
- Different ways to affect the elution rate/duration of release include, but are not limited to, including a non-active material in some of the coating retainers 22, changing the formulation of therapeutic agent within some of the coating retainers 22, creating a barrier layer over the therapeutic agent deposited in some of the coating retainers 22 and any combination thereof.
- the non-active material in the coating retainer 22 increases the surface area to volume ratio for the therapeutic agent, thereby affecting the duration of release of the therapeutic agent.
- Changing the formulation of therapeutic agent includes, but is not limited to, changing the ratios of therapeutic agents, changing the types of therapeutic agents, changing the loading of the therapeutic agent.
- a barrier layer over the therapeutic agent slows the release of therapeutic agent, thereby extending the therapeutic agent's duration of release.
- barrier layers are discussed in commonly assigned application Serial No. 11/857736, entitled Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface.
- Different release kinetics include rate of short term release, rate of long term release, local concentration of therapeutic agent and duration of effect.
- the rate of release can be modulated by drug/carrier ratios, surface area, total volume of therapeutic agent and macroscopic distribution of therapeutic agent in the vessel.
- any stent 10 configuration can be configured to deliver at least two therapeutic regimens.
- the embodiments shown in Figs. 3-7 illustrate the invention as applied to one side of the stent 10, e.g. abluminal. As discussed above, it is within the scope of the invention for both sides of the stent 10 to deliver multiple therapeutic regimens. Note that for simplicity, the stents 10 in Figs. 3-7 all have the same type of coating retainer 22 but it is within the scope of the invention for different regions and or subregions of the stent 10 to have different types of coating retainers 22, as discussed above.
- a stent 10 delivers different volumes of therapeutic agent from different regions of the stent 10. Different volumes of therapeutic agent can be delivered by different regions of the stent 10 due to different volumes of therapeutic agent deposited in/on coating retainers 22 of the different regions of the stent 10, different types of coating retainers 22 in each region of the stent 10, different sizes of coating retainers 22, different numbers of coating retainers 22 in each region of the stent 10, and any combination thereof. In at least one embodiment, different volumes of therapeutic agent are deposited in/on the coating retainers 22 of the different regions of the stent 10.
- all the coating retainers 22 on the stent 10 are the same size/volume and each region of the stent 10 has the same number of coating retainers 22 and different regions of the stent 10 have different volumes of therapeutic agent applied thereto.
- all the coating retainers 22 are sized to hold the greatest volume of therapeutic agent deposited onto the stent 10 and some coating retainers 22 have the greatest volumes deposited therein/thereon while some coating retainers 22 have smaller volumes of therapeutic agent deposited therein/on so that they are "under- filled” with therapeutic agent.
- the manufacture of the stent 10 is simplified since only one type and size of coating retainer 22 is required. Note that this stent 10 embodiment can also elute the same volume of therapeutic agent from the different regions of the stent 10, for example, when the same volume of therapeutic agent is applied to the entire stent 10.
- differentially sized coating retainers 22 are utilized on different regions of the stent 10.
- the volume/size of a coating retainer 22 depends upon the length, width, and depth of the coating retainer 22 and variation of at least one of the length, width and depth affects the volume of therapeutic agent that can be deposited on/in the coating retainer 22, and consequently the volume of, and/or local concentration of, therapeutic agent eluted from the coating retainer 22.
- the coating retainer 22 is a hole and the diameter of the hole affects the local concentration of therapeutic agent.
- the coating retainer 22 is in the form of a hole, for example, increasing the diameter of the coating retainer 22 increases the local concentration of therapeutic agent and decreasing the diameter of the coating retainer 22 decreases the local concentration of therapeutic agent.
- the local concentration of therapeutic agent is affected at a micrometer-level scale.
- the volume of therapeutic agent deposited onto a particular region of the stent 10 should be at least equal to the total volume of all the coating retainers 22 on that region so that each coating retainer 22 contains the maximum amount of therapeutic agent. Note that, as discussed in greater detail in Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface, Application Serial No. 11/857736, the volume of the therapeutic agent determines the length of time that the therapeutic agent elutes from the stent 10, i.e. the duration of release.
- coating retainers 22 with a greater volume of therapeutic agent deposited thereon/therein will elute the therapeutic agent for a longer time than a coating retainer 22 with a smaller volume of therapeutic agent deposited thereon/therein.
- at least one region of the stent 10 has a different number of coating retainers 22 than another region of the stent 10. A number of factors affect the number of coating retainers 22 in a region of the stent 10, for example, but not limited to, the density of coating retainers 22 in a region of the stent 10, the number of members 14 forming the region of the stent 10, the number of coating retainers 22 on each member 14 of a region of the stent 10, and any combination thereof.
- At least one region of the stent 10 has a different density of coating retainers 22.
- the density of coating retainers 22 is determined by the number of coating retainers 22 per unit of area.
- the density of the coating retainers 22 affects the local concentration of therapeutic agent.
- the local concentration of therapeutic agent is reduced when the spacing between coating retainers 22 is increased, i.e. the density of coating retainers 22 is low, and the local concentration of therapeutic agent is increased when the spacing between coating retainers 22 is decreased, i.e. the density of coating retainers 22 is high.
- the local concentration of therapeutic agent is affected on a millimeter-level scale. In Fig.
- the members 14 of the contralateral region 86 have a higher density of coating retainers 22 than the members 14 of the proximal main branch region 80a.
- the members 14 of the contralateral region 86 have a higher density of coating retainers 22 than the members 14 of the proximal main branch region 80a.
- the two regions of the stent 10 will have different numbers of coating retainers 22.
- different regions of the stent 10 have different densities of coating retainers 22 and the coating retainers 22 have different sizes. This can occur, for example, if the depth (thickness) of the members 14 with the higher density of coating retainers 22 is not sufficiently large to adjust the size of the coating retainer 22 so that it is the same as the size of the coating retainers 22 with a lower density without affecting the integrity of the member 14. In at least one embodiment, different regions of the stent 10 have different densities of coating retainers 22 and the coating retainers 22 have the same size.
- the greater depth of the higher density coating retainers 22 causes the higher density coating retainers 22 to elute therapeutic agent for a longer period of time than the lower density coating retainers 22 even though the same total amount of therapeutic agent would be eluted by both the higher density and the lower density coating retainers 22.
- a different number of members 14 comprise at least one region of the stent 10, where each member 14 has the same number of coating retainers 22.
- the density of the coating retainers 22 in the regions of the stent 10 can be the same or different so long as each member 14 of the stent 10 has the same number of coating retainers 22.
- different regions of the stent 10 have different numbers of circumferential rings 11 where each circumferential ring 11 comprises the same number of members 14.
- the proximal main branch region 80a has four circumferential rings 11 each comprising ten members 14 and the distal main branch region 80b has three circumferential rings 11 each comprising ten members 14, the proximal main branch region 80a has a greater number of coating retainers 22 than the distal main branch region 80b.
- different regions of the stent 10 have the same number of circumferential rings 11 but one region of the stent 10 has at least one circumferential ring 11 with a different number of members 14.
- the proximal main branch region 80a will have a greater number of coating retainers 22 where both the proximal main branch region 80a and the distal main branch region 80b have three circumferential rings 11 but the one of the circumferential rings 11 of the proximal main branch region 80a has a greater number of members 14 than the number of members 14 comprising the other circumferential rings 11.
- At least one region of the stent 10 has a different number of coating retainers 22 because it has a different number of members 14 and a different density of coating retainers 22 than another region of the stent 10.
- a region of the stent 10 with a greater number of members 14 and a higher density of coating retainers 22 will have more coating retainers 22 than another region of the stent 10 with a fewer number of members 14 and a lower density of coating retainers 22.
- a first region with a higher density of coating retainers 22 and fewer members 14 than a second region can be designed to have the same number of coating retainers 22 as the second region.
- different regions of the stent 10 have different numbers of coating retainers 22 on each member 14 of the region.
- the density of the coating retainers 22 is the same in different regions of the stent 10 but the total number of coating retainers 22 varies between regions of the stent 10.
- the different regions of the stent 10 have members 14 with different lengths.
- different members 14 of a region of the stent 10 have different lengths where the members 14 have different numbers of coating retainers 22 but the same density of coating retainers 22, as discussed below in reference to Fig. 7.
- FIG. 3-7 illustrate many of the design embodiments discussed above. As these non-limiting examples described below illustrate, there are numerous configurations and designs that exemplify embodiments of this invention.
- the stent 10 in Fig. 3 has a side branch 84 where each of the plurality of members 14 has three coating retainers 22 and a square shaped perimeter member 88 with seventy-six (76) coating retainers 22.
- the contralateral region 86 has a total of forty-eight (48) coating retainers 22. Note that the length of the members 14 in the side branch 84 is less than the length of the members 14 of the contralateral region 86 but the density of the coating retainers 22 is the same for both regions.
- the proximal main branch region 80a and the distal main branch region 80b each have a total of one hundred forty-four (144) coating retainers 22. Note that although the members 14 of the proximal main branch region 80a, the contralateral region 86 and the distal main branch region 80b each have four coating retainers 22, if all the coating retainers 22 are the same size, the contralateral region 86 elutes a smaller total volume of therapeutic agent than either the proximal main branch region 80a or the distal main branch region 80b.
- each of the proximal main branch region 80, the distal main branch region 8Ob 5 the contralateral region 86 and the members 14 of the side branch 84 will elute the therapeutic agent for the same amount of time.
- each member 14 of the side branch 84 has six coating retainers 22
- each member 14 of the contralateral region 86 has eight coating retainers 22
- each member 14 of the proximal and distal main branch regions 80a,b has four coating retainers 22.
- the perimeter member 88 in this embodiment has one hundred and twenty (120) coating retainers 22.
- the members 14 of the proximal main branch region 80a and the members 14 of the contralateral region 82 have the same length but the density of the coating retainers 22 of the proximal section 80 is half the density of the coating retainers 22 of the contralateral section 82.
- the proximal and distal main branch regions 80a,b each have a total of one hundred forty-four (144) coating retainers 22 while the contralateral region 86 has a total of one hundred ninety-two (192) coating retainers 22.
- the contralateral region 86 elutes a greater total volume of therapeutic agent than either the proximal main branch region 80a or the distal main branch region 80b.
- each member 14 of the side branch 84 has three coating retainers 22
- each member 14 of the contralateral region 86 has four coating retainers 22
- each member 14 of the proximal and distal main branch regions 80a,b have eight coating retainers 22
- the perimeter member 88 has sixty (60) coating retainers 22.
- the proximal and distal main branch regions 80a,b have a higher density of coating retainers 22 than the contralateral region 86 and the side branch region 84, and the contralateral region 86 has a greater density of coating retainers 22 than the side branch region 84.
- the stent 10 comprises three regions that have different densities of coating retainers 22.
- the proximal and distal main branch regions 80a,b each have a total of two hundred eighty-eight (288) coating retainers 22 while the contralateral region 86 has a total of ninety-six (96) coating retainers 22.
- the proximal main branch region 80a and the distal main branch region 80b each elute a greater volume of therapeutic agent than the contralateral region 86, in contrast to the stent 10 in Fig. 4. If the coating retainers 22 of the contralateral region 86 are larger than the coating retainers 22 of the proximal main branch region 80a and the distal main branch region 80b, the proximal and distal main branch regions 80a,b will elute therapeutic agent for a shorter period of time than the contralateral region 86.
- Figure 6 has the same configuration as Fig. 5 except that each member 14 of the side branch 84 has six coating retainers 22, instead of three coating retainers 22 as shown in Fig. 5. Since the length of the members 14 are substantially the same, the members 14 forming the side branch 84 of Fig. 6 have a greater density of coating retainers 22 than the members 14 of the side branch 84 in Fig. 5. In addition, the coating retainers 22 of the members 14 of the side branch 84 in Fig. 5 are larger than the coating retainers 22 of the members 14 of the side branch 84 in Fig. 6. Therefore, the side branch 84 of Fig. 5 will elute therapeutic agent for a longer period of time than the side branch 84 of Fig. 6.
- members 14a,b of the side branch 84 each have different numbers of coating retainers 22 (seven coating retainers 22 on member 14a and three coating retainers 22 on member 14b) although each member 14a,b has the same density of coating retainers 22 due to the different lengths of the members 14a,b.
- member 14a will elute a greater total volume of therapeutic agent than member 14b but both members 14a,b will elute the therapeutic agent for the same length of time if the coating retainers 22 are the same size.
- the side branch 84 which is in an expanded state, is at an oblique angle to the main branch 80 of the stent 10.
- the distal angle ( ⁇ ) of the side branch 84 to the proximal main branch region 80a is more acute than the proximal angle ( ⁇ ) of the side branch 84 to the distal main branch region 80b.
- the stress will also affect the length, width and depth of the coating retainers 22 on a member 14 as well as the distance between coating retainers 22 on a member 14. Because the perimeter member 88 is engaged to the member(s) 14 of the side branch 84, it also experiences stress that can affect the number and size of the coating retainers 22 positioned on the perimeter member 88.
- the members 14 of the side branch 84 have different lengths, with the proximal member 14a having a greater length than the distal member 14b.
- This design allows the members 14 of the side branch 84 to extend to a uniform distance into the side branch vessel when the side branch 84 is at an oblique angle to the main branch 80 of the stent 10. It is within the scope of the invention for the members 14 of the side branch 84 to have the same length.
- a stent having a body comprising a plurality of members, the plurality of members defining the body of the stent, the body comprising: a first region, the first region comprising a first plurality of first coating retainers, each of the first plurality of first coating retainers having a first volume and a first volume of therapeutic agent, the first plurality of first coating retainers eluting a first total volume of a first therapeutic agent; and a second region, the second region comprising a second plurality of second coating retainers, the second plurality of second coating retainers having a second volume and a second volume of second therapeutic agent, the second plurality of second coating retainers eluting a second total volume of a second therapeutic agent; wherein the first volume of each of the first plurality of first coating retainers is equal to the second volume each of the second plurality of second coating retainers, the first volume of first therapeutic agent is greater than the second volume of second therapeutic agent, and the first total volume of therapeutic agent is greater than the second total volume of therapeutic agent
- the stent of statement 1 the first therapeutic agent being different than the second therapeutic agent. 3.
- the stent of statement 1 each of the plurality of members having a width and a length, the width being substantially constant along the length of the member. 4.
- the stent of statement 1 each of the plurality of members having a thickness and a length, the thickness being substantially constant along the length of the member.
- a stent having a body comprising a plurality of members, the plurality of members defining the body of the stent, the body comprising: a first region, the first region having a plurality of first coating retainers, the plurality of first coating retainers having a first configuration, the first therapeutic agent eluting from the plurality of first coating retainers at a first elution rate; and a second region, the second region having a plurality of second coating retainers, the plurality of second coating retainers having a second configuration, the second therapeutic agent eluting from the plurality of second coating retainers at a second elution rate; wherein the first elution rate is greater than the second elution rate, and the first configuration of the first coating retainers is different from the second configuration of the second coating retainers.
- the stent of statement 1 the first region eluting a first total volume of therapeutic agent, the second therapeutic agent eluting a second total volume of therapeutic agent, the first total volume equal to the total second volume. 5. The stent of statement 1 , the first region eluting a first total volume of therapeutic agent, the second therapeutic agent eluting a second total volume of therapeutic agent, the first total volume greater than the second total volume.
- the stent of statement 5 the first configuration of the first coating retainers having a first volume, the second configuration of the second coating retainers having a second volume, the first volume equal to the second volume, the members of the first region having a first density of first coating retainers, the members of the second region having a second density of second coating retainers, the first density greater than the second density.
- the stent of statement 1 the plurality of first coating retainers being formed at least partially within the body of a plurality of the members comprising the first region of the stent.
- the plurality of second coating retainers being formed at least partially within the body of a plurality of the members comprising the second region of the stent.
- the stent of statement 1 wherein the first region is selected from at least one member of the group consisting of the luminal side, the abluminal side, the proximal region, the distal region, the middle region, the main body of a bifurcated stent, the contralateral region, the side branch of a bifurcated stent, members forming the side branch, the perimeter member and any combination thereof.
- the second region is selected from at least one member of the group consisting of the luminal side, the abluminal side, the proximal region, the distal region, the middle region, the main body of a bifurcated stent, the contralateral region, the side branch of a bifurcated stent, members forming the side branch, the perimeter member and any combination thereof, the second region being different than the first region.
- the stent of statement 1 the first configuration determined by a first length, a first width and a first depth and the second configuration determined by a second length, a second width and a second depth, wherein at least one of the first length, the first width and the first depth is different from at least one of the second length, the second width and the second depth so that the first size contains the first volume of first therapeutic agent and the second size contains the second volume of second therapeutic agent.
- the following numbered statements characterize at least one of the embodiments described above:
- a stent having a body comprising a plurality of members, the plurality of members defining the body of the stent, the body comprising: a first region, the first region comprising a plurality of first coating retainers, the first region having a first density of first coating retainers, the first region eluting a first total volume of first therapeutic agent from the first coating retainers; a second region, the second region comprising a plurality of second coating retainers, the second region having a second density of second coating retainers, the second region eluting a second total volume of second therapeutic agent from the second coating retainers; wherein the first density of first coating retainers is greater than the second density of second coating retainers and the first total volume of first therapeutic agent is greater than the second total volume of second therapeutic agent.
- each of the plurality of first coating retainers having a first configuration
- each of the plurality of second coating retainers having a second configuration, the first configuration different than the second configuration
- each of the plurality of first coating retainers having a first volume
- each of the plurality of second coating retainers having a second volume, the first volume of the first coating retainers being greater than the second volume of the second coating retainers.
- each of the plurality of first coating retainers having a first volume
- each of the plurality of second coating retainers having a second volume, the first volume being equal to the second volume
- each of the plurality of first coating retainers having a first volume of first therapeutic agent
- each of the plurality of second coating retainers having a second volume, the first volume of first therapeutic agent greater than the second volume of second therapeutic agent.
- the stent of statement 1 the plurality of first coating retainers being formed at least partially within the body of a plurality of the members comprising the first region of the stent. 7. The stent of statement 6, the plurality of second coating retainers being formed at least partially within the body of a plurality of the members comprising the second region of the stent.
- the first region is selected from at least one member of the group consisting of the luminal side, the abluminal side, the proximal region, the distal region, the middle region, the main body of a bifurcated stent, the contralateral region, the side branch of a bifurcated stent, members forming the side branch, the perimeter member and any combination thereof.
- the second region is selected from at least one member of the group consisting of the luminal side, the abluminal side, the proximal region, the distal region, the middle region, the main body of a bifurcated stent, the contralateral region, the side branch of a bifurcated stent, members forming the side branch, the perimeter member and any combination thereof, the second region being different than the first region.
- the stent of statement 1 further comprising a third region, the third region comprising a plurality of third coating retainers, the third region having a third density of third coating retainers, the third region eluting a third total volume of third therapeutic agent from the third coating retainers, wherein the density of the third coating retainers is different than the first and second densities and the third total volume of therapeutic agent is different than the first and second total volumes of therapeutic agent.
- the stent of statement 10 wherein the third region is selected from at least one member of the group consisting of the luminal side, the abluminal side, the proximal region, the distal region, the middle region, the main body of a bifurcated stent, the contralateral region, the side branch of a bifurcated stent, members forming the side branch, the perimeter member and any combination thereof, the third region being different than both the first and second regions.
- the inventive stents 10 may be made from any suitable biocompatible materials including one or more polymers, one or more metals or combinations of polymer(s) and metal(s). Examples of suitable materials include biodegradable or bioabsorbable materials that are also biocompatible.
- biodegradable is meant that a material will undergo breakdown or decomposition into harmless compounds as part of a normal biological process.
- Suitable biodegradable materials include polylactic acid, polyglycolic acid (PGA), collagen or other connective proteins or natural materials, polycaprolactone, hylauric acid, adhesive proteins, co-polymers of these materials as well as composites and combinations thereof and combinations of other biodegradable polymers.
- Other polymers that may be used include polyester and polycarbonate copolymers.
- suitable metals include, but are not limited to, stainless steel, titanium, tantalum, platinum, tungsten, gold and alloys of any of the above-mentioned metals.
- inventive stents may be made of shape memory materials such as superelastic Nitinol or spring steel, or may be made of materials which are plastically deformable. In the case of shape memory materials, the stent may be provided with a memorized shape and then deformed to a reduced diameter shape. The stent may restore itself to its memorized shape upon being heated to a transition temperature and having any restraints removed therefrom.
- the inventive stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids. Any other suitable technique which is known in the art or which is subsequently developed may also be used to manufacture the inventive stents disclosed herein.
- the stent, the delivery system or other portion of the assembly may include one or more areas, bands, coatings, members, etc. that is (are) detectable by imaging modalities such as X-Ray, MRI, ultrasound, etc.
- at least a portion of the stent and/or adjacent assembly is at least partially radiopaque.
- a therapeutic agent may be a drug or other pharmaceutical product such as non-genetic agents, genetic agents, cellular material, etc.
- suitable non- genetic therapeutic agents include but are not limited to: anti-thrombogenic agents such as heparin, heparin derivatives, vascular cell growth promoters, growth factor inhibitors, Paclitaxel, etc.
- an agent includes a genetic therapeutic agent, such a genetic agent may include but is not limited to: DNA, RNA and their respective derivatives and/or components; hedgehog proteins, etc.
- the cellular material may include but is not limited to: cells of human origin and/or non- human origin as well as their respective components and/or derivatives thereof.
- the therapeutic agent includes a polymer agent
- the polymer agent may be a polystyrene- polyisobutylene-polystyrene triblock copolymer (SIBS), polyethylene oxide, silicone rubber and/or any other suitable substrate.
- SIBS polystyrene- polyisobutylene-polystyrene triblock copolymer
- silicone rubber any other suitable substrate.
- any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims).
- each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims.
- the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010536049A JP2011504788A (en) | 2007-11-28 | 2008-11-12 | Bifurcated stent with drug wells for treatment of specific mouth, carina, and side branches |
CN200880118602XA CN101878008A (en) | 2007-11-28 | 2008-11-12 | The bifurcated stent that has the medicine trap that is used for concrete ostium, carina and side branch treatment |
CA2705356A CA2705356A1 (en) | 2007-11-28 | 2008-11-12 | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
EP08854983A EP2224886A1 (en) | 2007-11-28 | 2008-11-12 | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/946,632 | 2007-11-28 | ||
US11/946,632 US7833266B2 (en) | 2007-11-28 | 2007-11-28 | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009070447A1 true WO2009070447A1 (en) | 2009-06-04 |
Family
ID=40297683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/083248 WO2009070447A1 (en) | 2007-11-28 | 2008-11-12 | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
Country Status (6)
Country | Link |
---|---|
US (1) | US7833266B2 (en) |
EP (1) | EP2224886A1 (en) |
JP (1) | JP2011504788A (en) |
CN (1) | CN101878008A (en) |
CA (1) | CA2705356A1 (en) |
WO (1) | WO2009070447A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
US20100082096A1 (en) * | 2008-09-30 | 2010-04-01 | Boston Scientific Scimed, Inc. | Tailored Luminal & Abluminal Drug Elution |
US8616040B2 (en) * | 2010-09-17 | 2013-12-31 | Medtronic Vascular, Inc. | Method of forming a drug-eluting medical device |
US9811613B2 (en) | 2012-05-01 | 2017-11-07 | University Of Washington Through Its Center For Commercialization | Fenestration template for endovascular repair of aortic aneurysms |
CN104116577B (en) * | 2014-06-27 | 2017-07-14 | 先健科技(深圳)有限公司 | Branch type overlay film frame |
WO2016098113A1 (en) * | 2014-12-18 | 2016-06-23 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
EP3468505B1 (en) * | 2016-06-13 | 2021-02-24 | Aortica Corporation | Systems and devices for marking and/or reinforcing fenestrations in prosthetic implants |
EP3493766B1 (en) | 2016-08-02 | 2024-03-06 | Bolton Medical, Inc. | Assembly for coupling a prosthetic implant to a fenestrated body |
CN111148484B (en) | 2017-09-25 | 2022-12-30 | 波尔顿医疗公司 | Systems, devices, and methods for coupling a prosthetic implant to an open window |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0815806A2 (en) * | 1996-06-27 | 1998-01-07 | Cordis Corporation | Controlled porosity endovascular implant |
US20010029660A1 (en) * | 1997-09-30 | 2001-10-18 | Johnson Michael W. | Stent drug delivery system |
US20050266039A1 (en) * | 2004-05-27 | 2005-12-01 | Jan Weber | Coated medical device and method for making the same |
WO2006098889A2 (en) * | 2005-03-14 | 2006-09-21 | Conor Medsystems, Inc. | Expandable medical device with openings for delivery of multiple beneficial agents |
Family Cites Families (542)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2007A (en) * | 1841-03-16 | Improvement in the mode of harvesting grain | ||
US3948254A (en) | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
US4309994A (en) | 1980-02-25 | 1982-01-12 | Grunwald Ronald P | Cardiovascular cannula |
US4774949A (en) | 1983-06-14 | 1988-10-04 | Fogarty Thomas J | Deflector guiding catheter |
DE3516411A1 (en) | 1985-05-07 | 1986-11-13 | Plasmainvent AG, Zug | COATING OF AN IMPLANT BODY |
DE3689650T2 (en) | 1985-12-17 | 1994-05-26 | United States Surgical Corp | High molecular weight bioabsorbable polymers and implants thereof. |
DE3608158A1 (en) | 1986-03-12 | 1987-09-17 | Braun Melsungen Ag | VESSELED PROSTHESIS IMPREGNATED WITH CROSSLINED GELATINE AND METHOD FOR THE PRODUCTION THEREOF |
DE3715699A1 (en) | 1987-05-12 | 1988-12-01 | Foerster Ernst | CATHETER AND ENDOSCOPE FOR THE TRANSPAPILLARY DISPLAY OF THE GALLEN BLADDER |
US4935190A (en) | 1987-07-10 | 1990-06-19 | William G. Whitney | Method of making balloon retention catheter |
US4769005A (en) | 1987-08-06 | 1988-09-06 | Robert Ginsburg | Selective catheter guide |
US4896670A (en) | 1988-04-19 | 1990-01-30 | C. R. Bard, Inc. | Kissing balloon catheter |
US4906244A (en) | 1988-10-04 | 1990-03-06 | Cordis Corporation | Balloons for medical devices and fabrication thereof |
US5087246A (en) | 1988-12-29 | 1992-02-11 | C. R. Bard, Inc. | Dilation catheter with fluted balloon |
US5147302A (en) | 1989-04-21 | 1992-09-15 | Scimed Life Systems, Inc. | Method of shaping a balloon of a balloon catheter |
US4994071A (en) | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US5037392A (en) | 1989-06-06 | 1991-08-06 | Cordis Corporation | Stent-implanting balloon assembly |
US5318587A (en) | 1989-08-25 | 1994-06-07 | C. R. Bard, Inc. | Pleated balloon dilatation catheter and method of use |
US5147385A (en) | 1989-11-01 | 1992-09-15 | Schneider (Europe) A.G. | Stent and catheter for the introduction of the stent |
US5053007A (en) | 1989-12-14 | 1991-10-01 | Scimed Life Systems, Inc. | Compression balloon protector for a balloon dilatation catheter and method of use thereof |
US5320634A (en) | 1990-07-03 | 1994-06-14 | Interventional Technologies, Inc. | Balloon catheter with seated cutting edges |
US5163989A (en) | 1990-08-27 | 1992-11-17 | Advanced Cardiovascular Systems, Inc. | Method for forming a balloon mold and the use of such mold |
AR246020A1 (en) | 1990-10-03 | 1994-03-30 | Hector Daniel Barone Juan Carl | A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms. |
EP0479730B1 (en) | 1990-10-04 | 1995-04-19 | Schneider (Europe) Ag | Balloon dilatation catheter |
ES2257791T3 (en) | 1990-11-09 | 2006-08-01 | Boston Scientific Corporation | BALLOON FOR MEDICAL CATHETER. |
US5112900A (en) | 1990-11-28 | 1992-05-12 | Tactyl Technologies, Inc. | Elastomeric triblock copolymer compositions and articles made therewith |
US5628783A (en) | 1991-04-11 | 1997-05-13 | Endovascular Technologies, Inc. | Bifurcated multicapsule intraluminal grafting system and method |
US5304220A (en) | 1991-07-03 | 1994-04-19 | Maginot Thomas J | Method and apparatus for implanting a graft prosthesis in the body of a patient |
FR2678508B1 (en) | 1991-07-04 | 1998-01-30 | Celsa Lg | DEVICE FOR REINFORCING VESSELS OF THE HUMAN BODY. |
US5693084A (en) | 1991-10-25 | 1997-12-02 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm |
US5387235A (en) | 1991-10-25 | 1995-02-07 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm |
US5226887A (en) | 1992-02-07 | 1993-07-13 | Interventional Technologies, Inc. | Collapsible folding angioplasty balloon |
US5209799A (en) | 1992-04-17 | 1993-05-11 | Inverventional Technologies, Inc. | Method for manufacturing a folding balloon catheter |
US5342387A (en) | 1992-06-18 | 1994-08-30 | American Biomed, Inc. | Artificial support for a blood vessel |
US5447497A (en) | 1992-08-06 | 1995-09-05 | Scimed Life Systems, Inc | Balloon catheter having nonlinear compliance curve and method of using |
US5348538A (en) | 1992-09-29 | 1994-09-20 | Scimed Life Systems, Inc. | Shrinking balloon catheter having nonlinear or hybrid compliance curve |
US5449382A (en) | 1992-11-04 | 1995-09-12 | Dayton; Michael P. | Minimally invasive bioactivated endoprosthesis for vessel repair |
US5487730A (en) | 1992-12-30 | 1996-01-30 | Medtronic, Inc. | Balloon catheter with balloon surface retention means |
US5523092A (en) | 1993-04-14 | 1996-06-04 | Emory University | Device for local drug delivery and methods for using the same |
US5464650A (en) | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
IL106738A (en) | 1993-08-19 | 1998-02-08 | Mind E M S G Ltd | Device for external correction of deficient valves in venous junctions |
US5746745A (en) | 1993-08-23 | 1998-05-05 | Boston Scientific Corporation | Balloon catheter |
US5632772A (en) | 1993-10-21 | 1997-05-27 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
US5639278A (en) | 1993-10-21 | 1997-06-17 | Corvita Corporation | Expandable supportive bifurcated endoluminal grafts |
WO1995011270A1 (en) | 1993-10-21 | 1995-04-27 | Vista Chemical Company | Alumina thickened latex formulations |
US5350361A (en) | 1993-11-10 | 1994-09-27 | Medtronic, Inc. | Tri-fold balloon for dilatation catheter and related method |
US5607444A (en) | 1993-12-02 | 1997-03-04 | Advanced Cardiovascular Systems, Inc. | Ostial stent for bifurcations |
US5609627A (en) | 1994-02-09 | 1997-03-11 | Boston Scientific Technology, Inc. | Method for delivering a bifurcated endoluminal prosthesis |
US6146356A (en) | 1994-03-02 | 2000-11-14 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
US6171278B1 (en) | 1994-03-02 | 2001-01-09 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
US5830182A (en) | 1994-03-02 | 1998-11-03 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
US5951941A (en) | 1994-03-02 | 1999-09-14 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
US6406457B1 (en) | 1994-03-02 | 2002-06-18 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
DK0748232T4 (en) | 1994-03-02 | 2009-01-19 | Boston Scient Scimed Inc | Catheter balloons of block copolymer elastomers |
US5456666A (en) | 1994-04-26 | 1995-10-10 | Boston Scientific Corp | Medical balloon folding into predetermined shapes and method |
US5810767A (en) | 1994-05-11 | 1998-09-22 | Localmed, Inc. | Method and apparatus for pressurized intraluminal drug delivery |
US5683451A (en) | 1994-06-08 | 1997-11-04 | Cardiovascular Concepts, Inc. | Apparatus and methods for deployment release of intraluminal prostheses |
US5458572A (en) | 1994-07-01 | 1995-10-17 | Boston Scientific Corp. | Catheter with balloon folding into predetermined configurations and method of manufacture |
US5636641A (en) | 1994-07-25 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | High strength member for intracorporeal use |
US5609605A (en) | 1994-08-25 | 1997-03-11 | Ethicon, Inc. | Combination arterial stent |
US5891108A (en) | 1994-09-12 | 1999-04-06 | Cordis Corporation | Drug delivery stent |
CA2175720C (en) | 1996-05-03 | 2011-11-29 | Ian M. Penn | Bifurcated stent and method for the manufacture and delivery of same |
CA2134997C (en) | 1994-11-03 | 2009-06-02 | Ian M. Penn | Stent |
US5613980A (en) | 1994-12-22 | 1997-03-25 | Chauhan; Tusharsindhu C. | Bifurcated catheter system and method |
NL9500094A (en) | 1995-01-19 | 1996-09-02 | Industrial Res Bv | Y-shaped stent and method of deployment. |
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US20070073384A1 (en) | 1995-03-01 | 2007-03-29 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
DE69637527D1 (en) | 1995-03-01 | 2008-06-26 | Boston Scient Scimed Inc | Longitudinally flexible and expandable stent |
US5549552A (en) | 1995-03-02 | 1996-08-27 | Scimed Life Systems, Inc. | Balloon dilation catheter with improved pushability, trackability and crossability |
EP0813397A4 (en) | 1995-03-10 | 1999-10-06 | Cardiovascular Concepts Inc | Tubular endoluminar prosthesis having oblique ends |
US5605696A (en) | 1995-03-30 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Drug loaded polymeric material and method of manufacture |
US5709713A (en) | 1995-03-31 | 1998-01-20 | Cardiovascular Concepts, Inc. | Radially expansible vascular prosthesis having reversible and other locking structures |
US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US20020091433A1 (en) | 1995-04-19 | 2002-07-11 | Ni Ding | Drug release coated stent |
FR2733682B1 (en) | 1995-05-04 | 1997-10-31 | Dibie Alain | ENDOPROSTHESIS FOR THE TREATMENT OF STENOSIS ON BIFURCATIONS OF BLOOD VESSELS AND LAYING EQUIPMENT THEREFOR |
US5591228A (en) | 1995-05-09 | 1997-01-07 | Edoga; John K. | Methods for treating abdominal aortic aneurysms |
US5833657A (en) | 1995-05-30 | 1998-11-10 | Ethicon, Inc. | Single-walled balloon catheter with non-linear compliance characteristic |
US5707348A (en) | 1995-06-06 | 1998-01-13 | Krogh; Steve S. | Intravenous bandage |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US6280413B1 (en) | 1995-06-07 | 2001-08-28 | Medtronic Ave, Inc. | Thrombolytic filtration and drug delivery catheter with a self-expanding portion |
AU5776696A (en) | 1995-06-08 | 1997-01-09 | Bard Galway Limited | Bifurcated endovascular stent |
FR2737969B1 (en) | 1995-08-24 | 1998-01-30 | Rieu Regis | INTRALUMINAL ENDOPROSTHESIS IN PARTICULAR FOR ANGIOPLASTY |
US5824036A (en) | 1995-09-29 | 1998-10-20 | Datascope Corp | Stent for intraluminal grafts and device and methods for delivering and assembling same |
US5669924A (en) | 1995-10-26 | 1997-09-23 | Shaknovich; Alexander | Y-shuttle stent assembly for bifurcating vessels and method of using the same |
FR2740346A1 (en) | 1995-10-30 | 1997-04-30 | Debiotech Sa | ANGIOPLASTY DEVICE FOR ARTERIAL BIFURCATION |
US5632762A (en) | 1995-11-09 | 1997-05-27 | Hemodynamics, Inc. | Ostial stent balloon |
US5824040A (en) | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses and therapies for highly variable body lumens |
US5882334A (en) | 1995-12-04 | 1999-03-16 | Target Therapeutics, Inc. | Balloon/delivery catheter assembly with adjustable balloon positioning |
US6258116B1 (en) | 1996-01-26 | 2001-07-10 | Cordis Corporation | Bifurcated axially flexible stent |
US6017363A (en) | 1997-09-22 | 2000-01-25 | Cordis Corporation | Bifurcated axially flexible stent |
US6436104B2 (en) | 1996-01-26 | 2002-08-20 | Cordis Corporation | Bifurcated axially flexible stent |
US6124007A (en) | 1996-03-06 | 2000-09-26 | Scimed Life Systems Inc | Laminate catheter balloons with additive burst strength and methods for preparation of same |
US6071285A (en) | 1996-03-25 | 2000-06-06 | Lashinski; Robert D. | Rapid exchange folded balloon catheter and stent delivery system |
US5824042A (en) | 1996-04-05 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
BE1010183A3 (en) | 1996-04-25 | 1998-02-03 | Dereume Jean Pierre Georges Em | Luminal endoprosthesis FOR BRANCHING CHANNELS OF A HUMAN OR ANIMAL BODY AND MANUFACTURING METHOD THEREOF. |
US6783543B2 (en) | 2000-06-05 | 2004-08-31 | Scimed Life Systems, Inc. | Intravascular stent with increasing coating retaining capacity |
US5922021A (en) | 1996-04-26 | 1999-07-13 | Jang; G. David | Intravascular stent |
US6770092B2 (en) | 1996-05-03 | 2004-08-03 | Medinol Ltd. | Method of delivering a bifurcated stent |
US6440165B1 (en) | 1996-05-03 | 2002-08-27 | Medinol, Ltd. | Bifurcated stent with improved side branch aperture and method of making same |
US6251133B1 (en) | 1996-05-03 | 2001-06-26 | Medinol Ltd. | Bifurcated stent with improved side branch aperture and method of making same |
UA58485C2 (en) | 1996-05-03 | 2003-08-15 | Медінол Лтд. | Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants) |
US5851464A (en) | 1996-05-13 | 1998-12-22 | Cordis Corporation | Method of making a fuseless soft tip catheter |
US5718684A (en) | 1996-05-24 | 1998-02-17 | Gupta; Mukesh | Multi-lobed balloon catheter |
US5669932A (en) | 1996-05-29 | 1997-09-23 | Isostent, Inc. | Means for accurately positioning an expandable stent |
MX9800715A (en) | 1996-05-31 | 1998-04-30 | Bard Walway Ltd | Bifurcated endovascular stents and method and apparatus for their placement. |
US5617878A (en) | 1996-05-31 | 1997-04-08 | Taheri; Syde A. | Stent and method for treatment of aortic occlusive disease |
US5755773A (en) | 1996-06-04 | 1998-05-26 | Medtronic, Inc. | Endoluminal prosthetic bifurcation shunt |
US7238197B2 (en) | 2000-05-30 | 2007-07-03 | Devax, Inc. | Endoprosthesis deployment system for treating vascular bifurcations |
US8728143B2 (en) | 1996-06-06 | 2014-05-20 | Biosensors International Group, Ltd. | Endoprosthesis deployment system for treating vascular bifurcations |
FR2749500B1 (en) | 1996-06-06 | 1998-11-20 | Jacques Seguin | DEVICE ALLOWING THE TREATMENT OF BODY DUCTS AT THE LEVEL OF A BIFURCATION |
US5697971A (en) | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
US5797898A (en) | 1996-07-02 | 1998-08-25 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
US5676697A (en) | 1996-07-29 | 1997-10-14 | Cardiovascular Dynamics, Inc. | Two-piece, bifurcated intraluminal graft for repair of aneurysm |
US5922020A (en) | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
US5749825A (en) | 1996-09-18 | 1998-05-12 | Isostent, Inc. | Means method for treatment of stenosed arterial bifurcations |
US5755778A (en) | 1996-10-16 | 1998-05-26 | Nitinol Medical Technologies, Inc. | Anastomosis device |
US6692483B2 (en) | 1996-11-04 | 2004-02-17 | Advanced Stent Technologies, Inc. | Catheter with attached flexible side sheath |
EP1723931B1 (en) | 1996-11-04 | 2012-01-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus and method for deploying the same |
US7591846B2 (en) | 1996-11-04 | 2009-09-22 | Boston Scientific Scimed, Inc. | Methods for deploying stents in bifurcations |
US6325826B1 (en) | 1998-01-14 | 2001-12-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US7220275B2 (en) * | 1996-11-04 | 2007-05-22 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US6599316B2 (en) | 1996-11-04 | 2003-07-29 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6596020B2 (en) | 1996-11-04 | 2003-07-22 | Advanced Stent Technologies, Inc. | Method of delivering a stent with a side opening |
US6835203B1 (en) | 1996-11-04 | 2004-12-28 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US7341598B2 (en) | 1999-01-13 | 2008-03-11 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7229413B2 (en) | 1996-11-06 | 2007-06-12 | Angiotech Biocoatings Corp. | Echogenic coatings with overcoat |
US5972017A (en) | 1997-04-23 | 1999-10-26 | Vascular Science Inc. | Method of installing tubular medical graft connectors |
US6261320B1 (en) | 1996-11-21 | 2001-07-17 | Radiance Medical Systems, Inc. | Radioactive vascular liner |
FR2756173B1 (en) | 1996-11-22 | 1999-02-12 | Marcade Jean Paul | MODULAR AND EXPANDABLE ENDOPROSTHESIS FOR THE ARTERIAL NETWORK |
ZA9710342B (en) | 1996-11-25 | 1998-06-10 | Alza Corp | Directional drug delivery stent and method of use. |
US5749890A (en) | 1996-12-03 | 1998-05-12 | Shaknovich; Alexander | Method and system for stent placement in ostial lesions |
IT1289815B1 (en) | 1996-12-30 | 1998-10-16 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT AND RELATED PRODUCTION PROCESS |
DE29701758U1 (en) | 1997-02-01 | 1997-03-27 | Jomed Implantate Gmbh | Radially expandable stent for implantation in a body vessel, particularly in the area of a vascular branch |
DE29701883U1 (en) | 1997-02-04 | 1997-03-27 | Beck Harry | Central lubrication |
US5720735A (en) | 1997-02-12 | 1998-02-24 | Dorros; Gerald | Bifurcated endovascular catheter |
US6096073A (en) | 1997-02-25 | 2000-08-01 | Scimed Life Systems, Inc. | Method of deploying a stent at a lesion site located at a bifurcation in a parent vessel |
US20020133222A1 (en) | 1997-03-05 | 2002-09-19 | Das Gladwin S. | Expandable stent having a plurality of interconnected expansion modules |
US6139573A (en) | 1997-03-05 | 2000-10-31 | Scimed Life Systems, Inc. | Conformal laminate stent device |
US5815904A (en) | 1997-03-13 | 1998-10-06 | Intratherapeutics, Inc. | Method for making a stent |
US6240616B1 (en) | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US5843172A (en) | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
JP4083241B2 (en) | 1997-04-23 | 2008-04-30 | アーテミス・メディカル・インコーポレイテッド | Bifurcated stent and distal protection system |
US6033433A (en) | 1997-04-25 | 2000-03-07 | Scimed Life Systems, Inc. | Stent configurations including spirals |
US6013054A (en) | 1997-04-28 | 2000-01-11 | Advanced Cardiovascular Systems, Inc. | Multifurcated balloon catheter |
DE69835634T3 (en) | 1997-05-07 | 2010-09-23 | Cordis Corp. | Intravascular stent and insertion system (obstruction of the ostium of a vessel) |
ES2285770T3 (en) | 1997-05-12 | 2007-11-16 | Metabolix, Inc. | POLYHYDROXIALCANOATE FOR LIVE APPLICATIONS. |
DE29708803U1 (en) | 1997-05-17 | 1997-07-31 | Jomed Implantate Gmbh | Radially expandable stent for implantation in a body vessel in the area of a vascular branch |
CA2235911C (en) | 1997-05-27 | 2003-07-29 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
US5906641A (en) | 1997-05-27 | 1999-05-25 | Schneider (Usa) Inc | Bifurcated stent graft |
US6203536B1 (en) | 1997-06-17 | 2001-03-20 | Medtronic, Inc. | Medical device for delivering a therapeutic substance and method therefor |
EP0891751A1 (en) | 1997-07-18 | 1999-01-20 | Thomas Prof. Dr. Ischinger | Vascular stent for bifurcations, sidebranches and ostial lesions and an application catheter and method for implantation |
US5980564A (en) | 1997-08-01 | 1999-11-09 | Schneider (Usa) Inc. | Bioabsorbable implantable endoprosthesis with reservoir |
IT1293690B1 (en) | 1997-08-08 | 1999-03-08 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT, PARTICULARLY FOR THE TREATMENT OF AORTO-HOSPITAL AND HOSPITAL INJURIES. |
US6361544B1 (en) | 1997-08-13 | 2002-03-26 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6165195A (en) | 1997-08-13 | 2000-12-26 | Advanced Cardiovascylar Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6884429B2 (en) | 1997-09-05 | 2005-04-26 | Isotechnika International Inc. | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
US6520988B1 (en) | 1997-09-24 | 2003-02-18 | Medtronic Ave, Inc. | Endolumenal prosthesis and method of use in bifurcation regions of body lumens |
US6231598B1 (en) | 1997-09-24 | 2001-05-15 | Med Institute, Inc. | Radially expandable stent |
US6086611A (en) | 1997-09-25 | 2000-07-11 | Ave Connaught | Bifurcated stent |
US5928193A (en) | 1997-10-03 | 1999-07-27 | Boston Scientific Corporation | Balloon catheterization |
US6013091A (en) | 1997-10-09 | 2000-01-11 | Scimed Life Systems, Inc. | Stent configurations |
US5893887A (en) | 1997-10-14 | 1999-04-13 | Iowa-India Investments Company Limited | Stent for positioning at junction of bifurcated blood vessel and method of making |
US6273908B1 (en) | 1997-10-24 | 2001-08-14 | Robert Ndondo-Lay | Stents |
US6033435A (en) | 1997-11-03 | 2000-03-07 | Divysio Solutions Ulc | Bifurcated stent and method for the manufacture and delivery of same |
EP0951310B1 (en) | 1997-11-07 | 2005-05-18 | Ave Connaught | Balloon catheter for repairing bifurcated vessels |
WO1999023977A1 (en) | 1997-11-07 | 1999-05-20 | Expandable Grafts Partnership | Intravascular stent and method for manufacturing an intravascular stent |
US6030414A (en) | 1997-11-13 | 2000-02-29 | Taheri; Syde A. | Variable stent and method for treatment of arterial disease |
US6013055A (en) | 1997-11-13 | 2000-01-11 | Boston Scientific Corporation | Catheter balloon having selected folding characteristics |
US5961548A (en) | 1997-11-18 | 1999-10-05 | Shmulewitz; Ascher | Bifurcated two-part graft and methods of implantation |
US6129754A (en) | 1997-12-11 | 2000-10-10 | Uni-Cath Inc. | Stent for vessel with branch |
CA2220864A1 (en) | 1998-01-20 | 1999-07-20 | Nisar Huq | A bifurcation stent |
US6395018B1 (en) | 1998-02-09 | 2002-05-28 | Wilfrido R. Castaneda | Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels |
CA2320868C (en) | 1998-02-12 | 2008-08-12 | Thomas R. Marotta | Endovascular prosthesis |
US6033380A (en) | 1998-02-13 | 2000-03-07 | Cordis Corporation | Six-pleated catheter balloon and device for forming same |
WO1999040876A2 (en) | 1998-02-17 | 1999-08-19 | Jang G David | Tubular stent consists of chevron-shape expansion struts and ipsilaterally attached m-frame connectors |
US6113579A (en) | 1998-03-04 | 2000-09-05 | Scimed Life Systems, Inc. | Catheter tip designs and methods for improved stent crossing |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6099497A (en) | 1998-03-05 | 2000-08-08 | Scimed Life Systems, Inc. | Dilatation and stent delivery system for bifurcation lesions |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US7208011B2 (en) | 2001-08-20 | 2007-04-24 | Conor Medsystems, Inc. | Implantable medical device with drug filled holes |
US7179289B2 (en) | 1998-03-30 | 2007-02-20 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US6149957A (en) | 1998-04-09 | 2000-11-21 | Nestec S.A. | Aroma recovery process |
US6206916B1 (en) | 1998-04-15 | 2001-03-27 | Joseph G. Furst | Coated intraluminal graft |
US6093203A (en) | 1998-05-13 | 2000-07-25 | Uflacker; Renan | Stent or graft support structure for treating bifurcated vessels having different diameter portions and methods of use and implantation |
US6129757A (en) | 1998-05-18 | 2000-10-10 | Scimed Life Systems | Implantable members for receiving therapeutically useful compositions |
US6168621B1 (en) | 1998-05-29 | 2001-01-02 | Scimed Life Systems, Inc. | Balloon expandable stent with a self-expanding portion |
US6129738A (en) | 1998-06-20 | 2000-10-10 | Medtronic Ave, Inc. | Method and apparatus for treating stenoses at bifurcated regions |
US6652581B1 (en) | 1998-07-07 | 2003-11-25 | Boston Scientific Scimed, Inc. | Medical device with porous surface for controlled drug release and method of making the same |
US6261319B1 (en) | 1998-07-08 | 2001-07-17 | Scimed Life Systems, Inc. | Stent |
US6096175A (en) | 1998-07-17 | 2000-08-01 | Micro Therapeutics, Inc. | Thin film stent |
US6264662B1 (en) | 1998-07-21 | 2001-07-24 | Sulzer Vascutek Ltd. | Insertion aid for a bifurcated prosthesis |
US7967855B2 (en) | 1998-07-27 | 2011-06-28 | Icon Interventional Systems, Inc. | Coated medical device |
US20020038146A1 (en) | 1998-07-29 | 2002-03-28 | Ulf Harry | Expandable stent with relief cuts for carrying medicines and other materials |
US6143002A (en) | 1998-08-04 | 2000-11-07 | Scimed Life Systems, Inc. | System for delivering stents to bifurcation lesions |
US6299604B1 (en) * | 1998-08-20 | 2001-10-09 | Cook Incorporated | Coated implantable medical device |
US6117117A (en) | 1998-08-24 | 2000-09-12 | Advanced Cardiovascular Systems, Inc. | Bifurcated catheter assembly |
US6126652A (en) | 1998-09-08 | 2000-10-03 | Medtronic Inc. | Catheter balloon refolding tool and method of use |
US6206915B1 (en) | 1998-09-29 | 2001-03-27 | Medtronic Ave, Inc. | Drug storing and metering stent |
US6017324A (en) | 1998-10-20 | 2000-01-25 | Tu; Lily Chen | Dilatation catheter having a bifurcated balloon |
US6293967B1 (en) | 1998-10-29 | 2001-09-25 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
DE19855421C2 (en) | 1998-11-02 | 2001-09-20 | Alcove Surfaces Gmbh | Implant |
US6214042B1 (en) | 1998-11-10 | 2001-04-10 | Precision Vascular Systems, Inc. | Micro-machined stent for vessels, body ducts and the like |
FR2785812B1 (en) | 1998-11-16 | 2002-11-29 | Commissariat Energie Atomique | BIOACTIVE PROSTHESES, IN PARTICULAR WITH IMMUNOSUPPRESSIVE PROPERTIES, ANTISTENOSIS AND ANTITHROMBOSIS, AND THEIR MANUFACTURE |
US6063101A (en) | 1998-11-20 | 2000-05-16 | Precision Vascular Systems, Inc. | Stent apparatus and method |
AU1474700A (en) | 1998-12-11 | 2000-06-26 | Endologix, Inc. | Endoluminal vascular prosthesis |
US6059824A (en) | 1998-12-23 | 2000-05-09 | Taheri; Syde A. | Mated main and collateral stent and method for treatment of arterial disease |
US7655030B2 (en) | 2003-07-18 | 2010-02-02 | Boston Scientific Scimed, Inc. | Catheter balloon systems and methods |
US20050060027A1 (en) | 1999-01-13 | 2005-03-17 | Advanced Stent Technologies, Inc. | Catheter balloon systems and methods |
EP1150610A1 (en) | 1999-01-15 | 2001-11-07 | Ventrica Inc. | Methods and devices for forming vascular anastomoses |
IT1309583B1 (en) | 1999-02-26 | 2002-01-24 | Ams Italia S R L | PERFECTED CATHETER FOR VASCULAR INTERVENTIONS. |
US6261316B1 (en) | 1999-03-11 | 2001-07-17 | Endologix, Inc. | Single puncture bifurcation graft deployment system |
US6558422B1 (en) | 1999-03-26 | 2003-05-06 | University Of Washington | Structures having coated indentations |
US6258099B1 (en) | 1999-03-31 | 2001-07-10 | Scimed Life Systems, Inc. | Stent security balloon/balloon catheter |
US6325825B1 (en) | 1999-04-08 | 2001-12-04 | Cordis Corporation | Stent with variable wall thickness |
DE19921788A1 (en) | 1999-05-11 | 2000-11-16 | Jomed Implantate Gmbh | Device for implanting vascular supports |
US6290673B1 (en) | 1999-05-20 | 2001-09-18 | Conor Medsystems, Inc. | Expandable medical device delivery system and method |
US6884258B2 (en) | 1999-06-04 | 2005-04-26 | Advanced Stent Technologies, Inc. | Bifurcation lesion stent delivery using multiple guidewires |
US7387639B2 (en) | 1999-06-04 | 2008-06-17 | Advanced Stent Technologies, Inc. | Short sleeve stent delivery catheter and methods |
US6551351B2 (en) | 1999-07-02 | 2003-04-22 | Scimed Life Systems | Spiral wound stent |
US6258121B1 (en) | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
DE19934923A1 (en) | 1999-07-20 | 2001-01-25 | Biotronik Mess & Therapieg | Balloon catheter |
DE19938377A1 (en) | 1999-08-06 | 2001-03-01 | Biotronik Mess & Therapieg | Stent for vascular branching |
DE60018582T2 (en) | 1999-08-18 | 2006-01-19 | Microchips, Inc., Bedford | THERMALLY ACTIVATABLE MICROCHIP AS CHARGING DEVICE FOR CHEMICALS |
US6293968B1 (en) | 1999-09-02 | 2001-09-25 | Syde A. Taheri | Inflatable intraluminal vascular stent |
US6713119B2 (en) | 1999-09-03 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for a prosthesis and a method of forming the same |
US6287628B1 (en) | 1999-09-03 | 2001-09-11 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
US6379381B1 (en) | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
US6790228B2 (en) | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
WO2001021095A2 (en) | 1999-09-23 | 2001-03-29 | Advanced Stent Technologies, Inc. | Bifurcation stent system and method |
US6689156B1 (en) | 1999-09-23 | 2004-02-10 | Advanced Stent Technologies, Inc. | Stent range transducers and methods of use |
US6383213B2 (en) | 1999-10-05 | 2002-05-07 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6521284B1 (en) | 1999-11-03 | 2003-02-18 | Scimed Life Systems, Inc. | Process for impregnating a porous material with a cross-linkable composition |
EP2308522A3 (en) | 1999-11-17 | 2012-02-29 | Boston Scientific Limited | Microfabricated devices for the delivery of molecules into a carrier fluid |
US6387120B2 (en) | 1999-12-09 | 2002-05-14 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6808522B2 (en) | 1999-12-10 | 2004-10-26 | Massachusetts Institute Of Technology | Microchip devices for delivery of molecules and methods of fabrication thereof |
US6254593B1 (en) | 1999-12-10 | 2001-07-03 | Advanced Cardiovascular Systems, Inc. | Bifurcated stent delivery system having retractable sheath |
US6361555B1 (en) | 1999-12-15 | 2002-03-26 | Advanced Cardiovascular Systems, Inc. | Stent and stent delivery assembly and method of use |
US6471721B1 (en) | 1999-12-30 | 2002-10-29 | Advanced Cardiovascular Systems, Inc. | Vascular stent having increased radiopacity and method for making same |
CA2337565A1 (en) | 2000-02-25 | 2001-08-25 | Cordis Corporation | Use of cladribine on a stent to prevent restenosis |
ATE499988T1 (en) | 2000-03-02 | 2011-03-15 | Microchips Inc | MICROMECHANICAL DEVICES AND METHODS FOR STORAGE AND SELECTIVE EXPOSURE OF CHEMICALS |
ES2211791T3 (en) | 2000-03-03 | 2004-07-16 | Cook Incorporated | ENDOVASCULAR DEVICE THAT HAS A STENT. |
EP1132058A1 (en) | 2000-03-06 | 2001-09-12 | Advanced Laser Applications Holding S.A. | Intravascular prothesis |
US6379382B1 (en) | 2000-03-13 | 2002-04-30 | Jun Yang | Stent having cover with drug delivery capability |
US6210433B1 (en) | 2000-03-17 | 2001-04-03 | LARRé JORGE CASADO | Stent for treatment of lesions of bifurcated vessels |
US6468301B1 (en) | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Repositionable and recapturable vascular stent/graft |
US6423091B1 (en) | 2000-05-16 | 2002-07-23 | Cordis Corporation | Helical stent having flat ends |
US6334864B1 (en) | 2000-05-17 | 2002-01-01 | Aga Medical Corp. | Alignment member for delivering a non-symmetric device with a predefined orientation |
WO2001089420A2 (en) | 2000-05-19 | 2001-11-29 | Advanced Bio Prosthetic Surfaces, Ltd. | Methods and apparatus for manufacturing an intravascular stent |
AU2001261801A1 (en) | 2000-05-22 | 2001-12-03 | Orbus Medical Technologies Inc. | Self-expanding stent |
KR100360364B1 (en) | 2000-05-22 | 2002-11-13 | 주식회사 정성메디칼 | A metal stent for installation in the coronary artery |
US20040211362A1 (en) | 2000-05-31 | 2004-10-28 | Daniel Castro | System for coating a stent |
US6395326B1 (en) | 2000-05-31 | 2002-05-28 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for depositing a coating onto a surface of a prosthesis |
JP4754714B2 (en) | 2000-06-01 | 2011-08-24 | テルモ株式会社 | Intraluminal indwelling |
IL137090A (en) | 2000-06-29 | 2010-04-15 | Pentech Medical Devices Ltd | Polymeric stent |
US6585765B1 (en) | 2000-06-29 | 2003-07-01 | Advanced Cardiovascular Systems, Inc. | Implantable device having substances impregnated therein and a method of impregnating the same |
US6709451B1 (en) | 2000-07-14 | 2004-03-23 | Norman Noble, Inc. | Channeled vascular stent apparatus and method |
US7723303B2 (en) | 2000-08-24 | 2010-05-25 | The Regents Of The University Of California | Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
US7101391B2 (en) | 2000-09-18 | 2006-09-05 | Inflow Dynamics Inc. | Primarily niobium stent |
US6699278B2 (en) | 2000-09-22 | 2004-03-02 | Cordis Corporation | Stent with optimal strength and radiopacity characteristics |
US8070792B2 (en) | 2000-09-22 | 2011-12-06 | Boston Scientific Scimed, Inc. | Stent |
US6805898B1 (en) | 2000-09-28 | 2004-10-19 | Advanced Cardiovascular Systems, Inc. | Surface features of an implantable medical device |
US6716444B1 (en) | 2000-09-28 | 2004-04-06 | Advanced Cardiovascular Systems, Inc. | Barriers for polymer-coated implantable medical devices and methods for making the same |
US6254632B1 (en) | 2000-09-28 | 2001-07-03 | Advanced Cardiovascular Systems, Inc. | Implantable medical device having protruding surface structures for drug delivery and cover attachment |
AU2002224453A1 (en) | 2000-10-11 | 2002-04-22 | Microchips, Inc. | Microchip reservoir devices and facilitated corrosion of electrodes |
US6908477B2 (en) | 2000-10-13 | 2005-06-21 | Rex Medical, L.P. | Methods of implanting covered stents with side branch |
US6764507B2 (en) | 2000-10-16 | 2004-07-20 | Conor Medsystems, Inc. | Expandable medical device with improved spatial distribution |
PT1328213E (en) | 2000-10-16 | 2005-10-31 | Conor Medsystems Inc | EXPANSIVE MEDICAL DEVICE FOR THE ADMINISTRATION OF A BENEFICIAL AGENT |
US6506437B1 (en) | 2000-10-17 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device having depots formed in a surface thereof |
US6979347B1 (en) | 2000-10-23 | 2005-12-27 | Advanced Cardiovascular Systems, Inc. | Implantable drug delivery prosthesis |
US6663664B1 (en) | 2000-10-26 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with time variable radial force |
US6558733B1 (en) | 2000-10-26 | 2003-05-06 | Advanced Cardiovascular Systems, Inc. | Method for etching a micropatterned microdepot prosthesis |
US7416559B2 (en) | 2000-10-27 | 2008-08-26 | Poly-Med, Inc. | Micromantled drug-eluting stent |
US6758859B1 (en) | 2000-10-30 | 2004-07-06 | Kenny L. Dang | Increased drug-loading and reduced stress drug delivery device |
ATE367836T1 (en) | 2000-10-31 | 2007-08-15 | Cook Inc | COATED IMPLANTABLE MEDICAL DEVICES |
US6582394B1 (en) | 2000-11-14 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcated vessels |
US7425217B2 (en) | 2000-11-16 | 2008-09-16 | Maier Nathan C | System and method for inhibiting cellular proliferation with tachykinins |
US6645242B1 (en) | 2000-12-11 | 2003-11-11 | Stephen F. Quinn | Bifurcated side-access intravascular stent graft |
DE10064596A1 (en) | 2000-12-18 | 2002-06-20 | Biotronik Mess & Therapieg | Application of a marker element to an implant, especially a stent, comprises introducing a solidifiable material into a recess and solidifying the material in the recess |
US7083642B2 (en) * | 2000-12-22 | 2006-08-01 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
US6471980B2 (en) | 2000-12-22 | 2002-10-29 | Avantec Vascular Corporation | Intravascular delivery of mycophenolic acid |
US6824559B2 (en) | 2000-12-22 | 2004-11-30 | Advanced Cardiovascular Systems, Inc. | Ethylene-carboxyl copolymers as drug delivery matrices |
US6913617B1 (en) | 2000-12-27 | 2005-07-05 | Advanced Cardiovascular Systems, Inc. | Method for creating a textured surface on an implantable medical device |
AU2003279704A1 (en) | 2000-12-27 | 2004-04-08 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US6663662B2 (en) | 2000-12-28 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Diffusion barrier layer for implantable devices |
US6641607B1 (en) | 2000-12-29 | 2003-11-04 | Advanced Cardiovascular Systems, Inc. | Double tube stent |
US6635082B1 (en) | 2000-12-29 | 2003-10-21 | Advanced Cardiovascular Systems Inc. | Radiopaque stent |
US6544582B1 (en) | 2001-01-05 | 2003-04-08 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for coating an implantable device |
US6752829B2 (en) | 2001-01-30 | 2004-06-22 | Scimed Life Systems, Inc. | Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same |
US20040073294A1 (en) | 2002-09-20 | 2004-04-15 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
DE10107339A1 (en) | 2001-02-16 | 2002-09-05 | Jomed Gmbh | Implant used for treating vascular narrowing or occlusion, especially for controlling restenosis contains FK506 in chemically bound or physically fixed form |
KR20090130879A (en) | 2001-02-16 | 2009-12-24 | 애보트 래보러토리즈 배스큘라 엔터프라이지즈 리미티드 | Implants with fk506 |
US6695877B2 (en) | 2001-02-26 | 2004-02-24 | Scimed Life Systems | Bifurcated stent |
US7799064B2 (en) | 2001-02-26 | 2010-09-21 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
WO2002067653A2 (en) | 2001-02-26 | 2002-09-06 | Scimed Life Systems, Inc. | Bifurcated stent and delivery system |
US6679911B2 (en) | 2001-03-01 | 2004-01-20 | Cordis Corporation | Flexible stent |
WO2002069848A2 (en) | 2001-03-06 | 2002-09-12 | Board Of Regents, The University Of Texas System | Apparatus for stent deployment with delivery of bioactive agents |
FR2822370B1 (en) | 2001-03-23 | 2004-03-05 | Perouse Lab | TUBULAR ENDOPROSTHESIS COMPRISING A DEFORMABLE RING AND REQUIRED OF INTERVENTION FOR ITS IMPLANTATION |
US20020138136A1 (en) | 2001-03-23 | 2002-09-26 | Scimed Life Systems, Inc. | Medical device having radio-opacification and barrier layers |
WO2002076700A1 (en) | 2001-03-26 | 2002-10-03 | Machine Solutions, Inc. | Balloon folding technology |
US6780424B2 (en) | 2001-03-30 | 2004-08-24 | Charles David Claude | Controlled morphologies in polymer drug for release of drugs from polymer films |
US6764505B1 (en) | 2001-04-12 | 2004-07-20 | Advanced Cardiovascular Systems, Inc. | Variable surface area stent |
US7048939B2 (en) | 2001-04-20 | 2006-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for the inhibition of neointima formation |
US6712845B2 (en) | 2001-04-24 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | Coating for a stent and a method of forming the same |
US7232460B2 (en) | 2001-04-25 | 2007-06-19 | Xillus, Inc. | Nanodevices, microdevices and sensors on in-vivo structures and method for the same |
US6660034B1 (en) | 2001-04-30 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Stent for increasing blood flow to ischemic tissues and a method of using the same |
EP1254673B1 (en) | 2001-05-02 | 2005-11-09 | InFlow Dynamics, Inc. | Immuno-tolerant stent with surface microstructure |
US6749628B1 (en) | 2001-05-17 | 2004-06-15 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US8337540B2 (en) | 2001-05-17 | 2012-12-25 | Advanced Cardiovascular Systems, Inc. | Stent for treating bifurcations and method of use |
WO2002096389A1 (en) | 2001-05-30 | 2002-12-05 | Microchips, Inc. | Conformal coated microchip reservoir devices |
WO2002099457A1 (en) | 2001-05-31 | 2002-12-12 | Massachusetts Inst Technology | Microchip devices with improved reservoir opening |
US7201940B1 (en) | 2001-06-12 | 2007-04-10 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for thermal spray processing of medical devices |
DE10128436C1 (en) * | 2001-06-12 | 2003-04-10 | Integrated Electronic Systems Sys Consulting Gmbh | Hand control device with a joystick |
US20020193872A1 (en) | 2001-06-18 | 2002-12-19 | Trout Hugh H. | Prosthetic graft assembly and method of use |
US6527938B2 (en) | 2001-06-21 | 2003-03-04 | Syntheon, Llc | Method for microporous surface modification of implantable metallic medical articles |
EP1399135B1 (en) | 2001-06-28 | 2004-12-29 | Microchips, Inc. | Methods for hermetically sealing microchip reservoir devices |
EP1277449B2 (en) | 2001-07-20 | 2012-07-11 | Sorin Biomedica Cardio S.R.L. | Stent |
US6743259B2 (en) | 2001-08-03 | 2004-06-01 | Core Medical, Inc. | Lung assist apparatus and methods for use |
US7056338B2 (en) | 2003-03-28 | 2006-06-06 | Conor Medsystems, Inc. | Therapeutic agent delivery device with controlled therapeutic agent release rates |
EP1418863B1 (en) | 2001-08-23 | 2008-11-12 | Darrell C. Gumm | Rotating stent delivery system for side branch access and protection |
US20060224234A1 (en) | 2001-08-29 | 2006-10-05 | Swaminathan Jayaraman | Drug eluting structurally variable stent |
US6946092B1 (en) | 2001-09-10 | 2005-09-20 | Scimed Life Systems, Inc. | Medical balloon |
GB2379581B (en) | 2001-09-11 | 2005-08-31 | Nec Technologies | Apparatus and method of compensation for signal time-of-arrival variation in a UMTS handset |
US7252679B2 (en) | 2001-09-13 | 2007-08-07 | Cordis Corporation | Stent with angulated struts |
CN1585627A (en) | 2001-09-14 | 2005-02-23 | 弗朗西斯J·马丁 | Microfabricated nanopore device for sustained release of therapeutic agent |
US7004963B2 (en) | 2001-09-14 | 2006-02-28 | Scimed Life Systems, Inc. | Conformable balloons |
US20030060873A1 (en) | 2001-09-19 | 2003-03-27 | Nanomedical Technologies, Inc. | Metallic structures incorporating bioactive materials and methods for creating the same |
US6827737B2 (en) | 2001-09-25 | 2004-12-07 | Scimed Life Systems, Inc. | EPTFE covering for endovascular prostheses and method of manufacture |
US6753071B1 (en) | 2001-09-27 | 2004-06-22 | Advanced Cardiovascular Systems, Inc. | Rate-reducing membrane for release of an agent |
US7223282B1 (en) | 2001-09-27 | 2007-05-29 | Advanced Cardiovascular Systems, Inc. | Remote activation of an implantable device |
DE10150995A1 (en) | 2001-10-08 | 2003-04-10 | Biotronik Mess & Therapieg | Implant e.g. a stent, comprises a decomposable substance which allows contact between the cell proliferation inhibitor and the stent surroundings only after a specified time |
US7479149B2 (en) | 2001-10-25 | 2009-01-20 | Boston Scientific Scimed, Inc. | Balloon configuring apparatus |
EP1308179A1 (en) | 2001-10-30 | 2003-05-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Improved endoprosthetic device |
EP1310242A1 (en) | 2001-11-13 | 2003-05-14 | SORIN BIOMEDICA CARDIO S.p.A. | Carrier and kit for endoluminal delivery of active principles |
US7637932B2 (en) | 2001-11-28 | 2009-12-29 | Aptus Endosystems, Inc. | Devices, systems, and methods for prosthesis delivery and implantation |
US7014654B2 (en) | 2001-11-30 | 2006-03-21 | Scimed Life Systems, Inc. | Stent designed for the delivery of therapeutic substance or other agents |
WO2003048665A1 (en) | 2001-12-03 | 2003-06-12 | Massachusetts Institute Of Technology | Microscale lyophilization and drying methods for the stabilization of molecules |
US20030105512A1 (en) * | 2001-12-04 | 2003-06-05 | Nozomu Kanesaka | Stent containing medically treating material |
DE60106962T2 (en) | 2001-12-12 | 2005-04-28 | Hehrlein, Christoph, Dr. | Porous metallic stent with a coating |
US6752826B2 (en) | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
JP3947001B2 (en) * | 2001-12-27 | 2007-07-18 | 富士通株式会社 | Information recording medium and information storage device |
DE10200387B4 (en) | 2002-01-08 | 2009-11-26 | Translumina Gmbh | stent |
US6939368B2 (en) | 2002-01-17 | 2005-09-06 | Scimed Life Systems, Inc. | Delivery system for self expanding stents for use in bifurcated vessels |
US6864418B2 (en) | 2002-12-18 | 2005-03-08 | Nanoset, Llc | Nanomagnetically shielded substrate |
US20030153901A1 (en) | 2002-02-08 | 2003-08-14 | Atrium Medical Corporation | Drug delivery panel |
US7758605B2 (en) | 2002-02-28 | 2010-07-20 | Boston Scientific Scimed, Inc. | Balloon folding apparatus, methods and products |
US7951164B2 (en) | 2002-02-28 | 2011-05-31 | Boston Scientific Scimed, Inc. | Balloon folding apparatus, methods and products |
EP1348402A1 (en) | 2002-03-29 | 2003-10-01 | Advanced Laser Applications Holding S.A. | Intraluminal endoprosthesis, radially expandable, perforated for drug delivery |
EP1362603B1 (en) | 2002-05-14 | 2006-03-01 | Terumo Kabushiki Kaisha | Coated stent for release of active agents |
US20040000540A1 (en) | 2002-05-23 | 2004-01-01 | Soboyejo Winston O. | Laser texturing of surfaces for biomedical implants |
US20040117003A1 (en) | 2002-05-28 | 2004-06-17 | The Cleveland Clinic Foundation | Minimally invasive treatment system for aortic aneurysms |
US6858038B2 (en) | 2002-06-21 | 2005-02-22 | Richard R. Heuser | Stent system |
US20040133270A1 (en) | 2002-07-08 | 2004-07-08 | Axel Grandt | Drug eluting stent and methods of manufacture |
AU2003256499A1 (en) | 2002-07-11 | 2004-02-02 | Setagon, Inc. | Expandable body having deployable microstructures and related methods |
US6761734B2 (en) | 2002-07-22 | 2004-07-13 | William S. Suhr | Segmented balloon catheter for stenting bifurcation lesions |
US7255710B2 (en) | 2002-08-06 | 2007-08-14 | Icon Medical Corp. | Helical stent with micro-latches |
US6962822B2 (en) | 2002-08-07 | 2005-11-08 | International Business Machines Corporation | Discrete nano-textured structures in biomolecular arrays, and method of use |
US7951392B2 (en) | 2002-08-16 | 2011-05-31 | Boston Scientific Scimed, Inc. | Microarray drug delivery coatings |
EP1391184A1 (en) | 2002-08-16 | 2004-02-25 | Endosense Sàrl | Extensible multilayer tubular structure and production method therefor |
JP4436258B2 (en) | 2002-08-16 | 2010-03-24 | マイクロチップス・インコーポレーテッド | Controlled release device and method |
WO2004026174A2 (en) | 2002-09-20 | 2004-04-01 | Conor Medsystems, Inc. | Expandable medical device with openings for delivery of multiple beneficial agents |
US20040127976A1 (en) | 2002-09-20 | 2004-07-01 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
US20040059406A1 (en) | 2002-09-20 | 2004-03-25 | Cully Edward H. | Medical device amenable to fenestration |
ATE392864T1 (en) | 2002-09-20 | 2008-05-15 | Abbott Lab Vascular Entpr Ltd | STENT PROVIDED WITH A ROUGH SURFACE AND METHOD OF PRODUCTION THEREOF |
US9498358B2 (en) | 2002-09-20 | 2016-11-22 | Innovational Holdings Llc | Implantable medical device with openings for delivery of beneficial agents with combination release kinetics |
US7001422B2 (en) | 2002-09-23 | 2006-02-21 | Cordis Neurovascular, Inc | Expandable stent and delivery system |
US7534241B2 (en) | 2002-09-23 | 2009-05-19 | Microchips, Inc. | Micro-reservoir osmotic release systems and microtube array device |
CA2499976C (en) | 2002-09-26 | 2013-06-11 | Advanced Bio Prosthetic Surfaces, Ltd. | Implantable materials having engineered surfaces and method of making same |
US7135038B1 (en) | 2002-09-30 | 2006-11-14 | Advanced Cardiovascular Systems, Inc. | Drug eluting stent |
US20040068161A1 (en) | 2002-10-02 | 2004-04-08 | Couvillon Lucien Alfred | Thrombolysis catheter |
US20040088038A1 (en) | 2002-10-30 | 2004-05-06 | Houdin Dehnad | Porous metal for drug-loaded stents |
US7326242B2 (en) | 2002-11-05 | 2008-02-05 | Boston Scientific Scimed, Inc. | Asymmetric bifurcated crown |
EP1562517B1 (en) | 2002-11-07 | 2010-06-16 | Abbott Laboratories | Prosthesis with multiple drugs in discrete unmixed droplets |
CA2513721C (en) | 2002-11-08 | 2013-04-16 | Conor Medsystems, Inc. | Method and apparatus for reducing tissue damage after ischemic injury |
US20040142014A1 (en) | 2002-11-08 | 2004-07-22 | Conor Medsystems, Inc. | Method and apparatus for reducing tissue damage after ischemic injury |
AU2003291470A1 (en) | 2002-11-08 | 2004-06-03 | Innovational Holdings, Llc | Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor |
US7169178B1 (en) | 2002-11-12 | 2007-01-30 | Advanced Cardiovascular Systems, Inc. | Stent with drug coating |
ATE402675T1 (en) | 2002-11-13 | 2008-08-15 | Setagon Inc | MEDICAL DEVICES WITH POROUS LAYERS AND PRODUCTION PROCESSES THEREOF |
US8449601B2 (en) | 2002-11-19 | 2013-05-28 | Boston Scientific Scimed, Inc. | Medical devices |
US20050095267A1 (en) | 2002-12-04 | 2005-05-05 | Todd Campbell | Nanoparticle-based controlled release polymer coatings for medical implants |
US7044965B1 (en) | 2002-12-13 | 2006-05-16 | Spielberg Theodore E | Therapeutic cellular stent |
US20050165469A1 (en) | 2002-12-24 | 2005-07-28 | Michael Hogendijk | Vascular prosthesis including torsional stabilizer and methods of use |
US6725901B1 (en) | 2002-12-27 | 2004-04-27 | Advanced Cardiovascular Systems, Inc. | Methods of manufacture of fully consolidated or porous medical devices |
US7105018B1 (en) | 2002-12-30 | 2006-09-12 | Advanced Cardiovascular Systems, Inc. | Drug-eluting stent cover and method of use |
US6896697B1 (en) | 2002-12-30 | 2005-05-24 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US7316710B1 (en) | 2002-12-30 | 2008-01-08 | Advanced Cardiovascular Systems, Inc. | Flexible stent |
KR100495875B1 (en) | 2003-01-18 | 2005-06-16 | 사회복지법인 삼성생명공익재단 | Stent for percutaneous coronary intervention coated with drugs for the prevention of vascular restenosis |
GB2397233A (en) | 2003-01-20 | 2004-07-21 | Julie Gold | Biomedical device with bioerodable coating |
US6852122B2 (en) | 2003-01-23 | 2005-02-08 | Cordis Corporation | Coated endovascular AAA device |
US20050079199A1 (en) | 2003-02-18 | 2005-04-14 | Medtronic, Inc. | Porous coatings for drug release from medical devices |
US20040167572A1 (en) | 2003-02-20 | 2004-08-26 | Roth Noah M. | Coated medical devices |
ES2354605T3 (en) | 2003-02-21 | 2011-03-16 | Sorin Biomedica Cardio S.R.L. | STENTS PRODUCTION PROCEDURE AND THE CORRESPONDING STENT. |
US7314480B2 (en) | 2003-02-27 | 2008-01-01 | Boston Scientific Scimed, Inc. | Rotating balloon expandable sheath bifurcation delivery |
US8281737B2 (en) | 2003-03-10 | 2012-10-09 | Boston Scientific Scimed, Inc. | Coated medical device and method for manufacturing the same |
US20040202692A1 (en) | 2003-03-28 | 2004-10-14 | Conor Medsystems, Inc. | Implantable medical device and method for in situ selective modulation of agent delivery |
US7163555B2 (en) | 2003-04-08 | 2007-01-16 | Medtronic Vascular, Inc. | Drug-eluting stent for controlled drug delivery |
US7731747B2 (en) | 2003-04-14 | 2010-06-08 | Tryton Medical, Inc. | Vascular bifurcation prosthesis with multiple thin fronds |
CA2523432C (en) | 2003-04-25 | 2014-10-28 | Microchips, Inc. | Solid drug formulation and device for storage and controlled delivery thereof |
US8246974B2 (en) | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
US20040225345A1 (en) | 2003-05-05 | 2004-11-11 | Fischell Robert E. | Means and method for stenting bifurcated vessels |
US6846323B2 (en) | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
ES2660627T3 (en) | 2003-05-15 | 2018-03-23 | Biomerix Corporation | Crosslinked elastomeric matrices, their manufacture and their use in implantable devices |
US20040236416A1 (en) | 2003-05-20 | 2004-11-25 | Robert Falotico | Increased biocompatibility of implantable medical devices |
US20030216803A1 (en) | 2003-05-28 | 2003-11-20 | Ledergerber Walter J. | Textured and drug eluting stent-grafts |
US6904658B2 (en) | 2003-06-02 | 2005-06-14 | Electroformed Stents, Inc. | Process for forming a porous drug delivery layer |
US7169179B2 (en) | 2003-06-05 | 2007-01-30 | Conor Medsystems, Inc. | Drug delivery device and method for bi-directional drug delivery |
US7114312B2 (en) | 2003-07-17 | 2006-10-03 | Microchips, Inc. | Low temperature methods for hermetically sealing reservoir devices |
US20050021127A1 (en) | 2003-07-21 | 2005-01-27 | Kawula Paul John | Porous glass fused onto stent for drug retention |
US20050027350A1 (en) | 2003-07-30 | 2005-02-03 | Biotronik Mess-Und Therapiegeraete Gmbh & Co Ingenieurbuero Berlin | Endovascular implant for the injection of an active substance into the media of a blood vessel |
US20050033417A1 (en) | 2003-07-31 | 2005-02-10 | John Borges | Coating for controlled release of a therapeutic agent |
US8298280B2 (en) | 2003-08-21 | 2012-10-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US20050055080A1 (en) | 2003-09-05 | 2005-03-10 | Naim Istephanous | Modulated stents and methods of making the stents |
US7488343B2 (en) | 2003-09-16 | 2009-02-10 | Boston Scientific Scimed, Inc. | Medical devices |
US20050060020A1 (en) | 2003-09-17 | 2005-03-17 | Scimed Life Systems, Inc. | Covered stent with biologically active material |
US7055237B2 (en) | 2003-09-29 | 2006-06-06 | Medtronic Vascular, Inc. | Method of forming a drug eluting stent |
US8808351B2 (en) | 2003-10-10 | 2014-08-19 | Cook Medical Technologies Llc | Stretchable prosthesis fenestration |
EP1682041A2 (en) | 2003-10-10 | 2006-07-26 | QUADRI, Arshad | System and method for endoluminal grafting of bifurcated and branched vessels |
US7070616B2 (en) | 2003-10-31 | 2006-07-04 | Cordis Corporation | Implantable valvular prosthesis |
CA2544416A1 (en) | 2003-11-03 | 2005-05-12 | B-Balloon Ltd. | Treatment of vascular bifurcations |
US7338509B2 (en) | 2003-11-06 | 2008-03-04 | Boston Scientific Scimed, Inc. | Electroactive polymer actuated sheath for implantable or insertable medical device |
US9078780B2 (en) | 2003-11-08 | 2015-07-14 | Cook Medical Technologies Llc | Balloon flareable branch vessel prosthesis and method |
EP1688155A4 (en) | 2003-11-28 | 2008-02-20 | Zeon Medical Inc | Cell growth-inhibiting film, medical instrument and stent for digestive organs |
US20050119723A1 (en) | 2003-11-28 | 2005-06-02 | Medlogics Device Corporation | Medical device with porous surface containing bioerodable bioactive composites and related methods |
JP2005160600A (en) | 2003-12-01 | 2005-06-23 | Ir:Kk | Liquid impregnating stent and liquid medication impregnating stent |
US6997989B2 (en) | 2003-12-08 | 2006-02-14 | Boston Scientific Scimed, Inc. | Medical implant processing chamber |
US20050131526A1 (en) | 2003-12-10 | 2005-06-16 | Shing-Chiu Wong | Stent and balloon system for bifurcated vessels and lesions |
US20050137679A1 (en) | 2003-12-17 | 2005-06-23 | Pfizer Inc | Modified stent useful for delivery of drugs along stent strut |
US20050137677A1 (en) | 2003-12-17 | 2005-06-23 | Rush Scott L. | Endovascular graft with differentiable porosity along its length |
US8652502B2 (en) | 2003-12-19 | 2014-02-18 | Cordis Corporation | Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury |
US7686841B2 (en) | 2003-12-29 | 2010-03-30 | Boston Scientific Scimed, Inc. | Rotating balloon expandable sheath bifurcation delivery system |
US7922753B2 (en) | 2004-01-13 | 2011-04-12 | Boston Scientific Scimed, Inc. | Bifurcated stent delivery system |
US20050159805A1 (en) | 2004-01-20 | 2005-07-21 | Jan Weber | Functional coatings and designs for medical implants |
ITTO20040056A1 (en) | 2004-02-05 | 2004-05-05 | Sorin Biomedica Cardio Spa | STENT FOR THE ENDOLIMINAL DELIVERY OF PRINCIPLES OR ACTIVE AGENTS |
GB0402736D0 (en) | 2004-02-06 | 2004-03-10 | Tayside Flow Technologies Ltd | A drug delivery device |
US7981441B2 (en) | 2004-02-18 | 2011-07-19 | The Board Of Trustees Of The Leland Stanford Junior University | Drug delivery systems using mesoporous oxide films |
US7225518B2 (en) | 2004-02-23 | 2007-06-05 | Boston Scientific Scimed, Inc. | Apparatus for crimping a stent assembly |
US7744619B2 (en) | 2004-02-24 | 2010-06-29 | Boston Scientific Scimed, Inc. | Rotatable catheter assembly |
US8137397B2 (en) | 2004-02-26 | 2012-03-20 | Boston Scientific Scimed, Inc. | Medical devices |
FR2867059B1 (en) | 2004-03-03 | 2006-05-26 | Braun Medical | ENDOPROTHESIS WITH MARKERS FOR CONDUCTING A LIVING BODY |
US20050209673A1 (en) | 2004-03-04 | 2005-09-22 | Y Med Inc. | Bifurcation stent delivery devices |
US7744644B2 (en) | 2004-03-19 | 2010-06-29 | Boston Scientific Scimed, Inc. | Medical articles having regions with polyelectrolyte multilayer coatings for regulating drug release |
WO2005089673A1 (en) | 2004-03-24 | 2005-09-29 | Mika Lahtinen | New product |
US20050228477A1 (en) | 2004-04-09 | 2005-10-13 | Xtent, Inc. | Topographic coatings and coating methods for medical devices |
US20050228491A1 (en) | 2004-04-12 | 2005-10-13 | Snyder Alan J | Anti-adhesive surface treatments |
CA2502018A1 (en) | 2004-04-16 | 2005-10-16 | Conor Medsystems, Inc. | Bioresorbable stent delivery system |
WO2005110285A2 (en) | 2004-04-30 | 2005-11-24 | Gmp/Cardiac Care, Inc. | Variable wall endovascular stent |
US20050251245A1 (en) | 2004-05-05 | 2005-11-10 | Karl Sieradzki | Methods and apparatus with porous materials |
US8048149B2 (en) | 2004-05-13 | 2011-11-01 | Medtronic Vascular, Inc. | Intraluminal stent including therapeutic agent delivery pads, and method of manufacturing the same |
US20050261757A1 (en) | 2004-05-21 | 2005-11-24 | Conor Medsystems, Inc. | Stent with contoured bridging element |
ATE423578T1 (en) | 2004-05-27 | 2009-03-15 | Medtronic Inc | MEDICAL DEVICE WITH A BIOLOGICAL ACTIVE SUBSTANCE |
US20050266040A1 (en) | 2004-05-28 | 2005-12-01 | Brent Gerberding | Medical devices composed of porous metallic materials for delivering biologically active materials |
WO2005122959A2 (en) | 2004-06-08 | 2005-12-29 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US20050273149A1 (en) | 2004-06-08 | 2005-12-08 | Tran Thomas T | Bifurcated stent delivery system |
EP1604697A1 (en) | 2004-06-09 | 2005-12-14 | J.A.C.C. GmbH | Implantable device |
US20050278929A1 (en) | 2004-06-16 | 2005-12-22 | National Taipei University Technology | Process of manufacturing stent with therapeutic function in the human body |
US7585318B2 (en) | 2004-06-18 | 2009-09-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US20050287287A1 (en) | 2004-06-24 | 2005-12-29 | Parker Theodore L | Methods and systems for loading an implantable medical device with beneficial agent |
USD516723S1 (en) | 2004-07-06 | 2006-03-07 | Conor Medsystems, Inc. | Stent wall structure |
US7972351B2 (en) | 2004-07-13 | 2011-07-05 | Boston Scientific Scimed, Inc. | Balloon folding design and method and apparatus for making balloons |
US20060025848A1 (en) | 2004-07-29 | 2006-02-02 | Jan Weber | Medical device having a coating layer with structural elements therein and method of making the same |
US20060034884A1 (en) | 2004-08-10 | 2006-02-16 | Stenzel Eric B | Coated medical device having an increased coating surface area |
US20060041303A1 (en) | 2004-08-18 | 2006-02-23 | Israel Henry M | Guidewire with stopper |
US8119153B2 (en) | 2004-08-26 | 2012-02-21 | Boston Scientific Scimed, Inc. | Stents with drug eluting coatings |
WO2006028925A1 (en) | 2004-09-02 | 2006-03-16 | Med Institute, Inc. | Modular prosthesis and method for branch vessels |
US7507433B2 (en) | 2004-09-03 | 2009-03-24 | Boston Scientific Scimed, Inc. | Method of coating a medical device using an electrowetting process |
US7229471B2 (en) | 2004-09-10 | 2007-06-12 | Advanced Cardiovascular Systems, Inc. | Compositions containing fast-leaching plasticizers for improved performance of medical devices |
US20060079956A1 (en) | 2004-09-15 | 2006-04-13 | Conor Medsystems, Inc. | Bifurcation stent with crushable end and method for delivery of a stent to a bifurcation |
DE102004044738A1 (en) | 2004-09-15 | 2006-03-16 | Technische Universität München | Process for producing a structuring of metal surfaces and components produced by this process |
US7901451B2 (en) | 2004-09-24 | 2011-03-08 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US20060085065A1 (en) | 2004-10-15 | 2006-04-20 | Krause Arthur A | Stent with auxiliary treatment structure |
US20060093643A1 (en) | 2004-11-04 | 2006-05-04 | Stenzel Eric B | Medical device for delivering therapeutic agents over different time periods |
US7413846B2 (en) | 2004-11-15 | 2008-08-19 | Microchips, Inc. | Fabrication methods and structures for micro-reservoir devices |
US20060129215A1 (en) | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery |
US20060129225A1 (en) | 2004-12-15 | 2006-06-15 | Kopia Gregory A | Device for the delivery of a cardioprotective agent to ischemic reperfused myocardium |
JP2006175017A (en) | 2004-12-22 | 2006-07-06 | Homuzu Giken:Kk | Manufacturing method of stent and stent |
ATE508714T1 (en) | 2005-01-10 | 2011-05-15 | Trireme Medical Inc | STENT WITH SELF-EXPANDABLE AREA |
FR2880796B1 (en) | 2005-01-18 | 2008-02-22 | Novatech Sa Sa | ENDOPROTHESIS FOR ANOTOMIC CHANNEL |
CA2595457A1 (en) | 2005-01-25 | 2006-08-03 | Microchips, Inc. | Control of drug release by transient modification of local microenvironments |
US8057543B2 (en) | 2005-01-28 | 2011-11-15 | Greatbatch Ltd. | Stent coating for eluting medication |
US20060235504A1 (en) | 2005-02-10 | 2006-10-19 | Clear Vascular, Inc. | Methods and apparatus for treatment of luminal hyperplasia |
DE102005010100A1 (en) | 2005-03-02 | 2006-09-14 | Hehrlein, Friedrich Wilhelm, Prof. Dr. Dr. | Medical instrument with an asymmetrical microcrater in outer surface and a medicament holding fatty acid layer useful in administration of slow release drugs, e.g. in angioplasty, where medicament fatty acid layer can be mxied with acetone |
US20060200229A1 (en) | 2005-03-03 | 2006-09-07 | Robert Burgermeister | Geometry and material for use in high strength, high flexibility, controlled recoil drug eluting stents |
EP1858440B1 (en) | 2005-03-03 | 2024-04-24 | MiRus LLC | Improved metal alloys for medical device |
US8323333B2 (en) | 2005-03-03 | 2012-12-04 | Icon Medical Corp. | Fragile structure protective coating |
US20070255094A1 (en) | 2005-03-14 | 2007-11-01 | Oepen Randolf V | Crack/fatigue resistant endoprosthesis |
US8353944B2 (en) | 2005-03-14 | 2013-01-15 | Boston Scientific Scimed, Inc. | Bifurcation delivery system |
US7998195B2 (en) | 2005-03-25 | 2011-08-16 | Boston Scientific Scimed, Inc. | Device with engineered surface architecture coating for controlled drug release |
CA2603851A1 (en) | 2005-04-11 | 2006-10-19 | The Board Of Trustees Of The Leland Stanford Junior Unversity | Multi-layer structure having a predetermined layer pattern including an agent |
US7309353B2 (en) | 2005-04-29 | 2007-12-18 | Medtronic Vascular, Inc. | Use of platinum group metals in vascular devices and method of texturing platinum group metals |
US10076641B2 (en) | 2005-05-11 | 2018-09-18 | The Spectranetics Corporation | Methods and systems for delivering substances into luminal walls |
US10092429B2 (en) | 2005-08-22 | 2018-10-09 | Incept, Llc | Flared stents and apparatus and methods for delivering them |
US8480728B2 (en) | 2005-05-26 | 2013-07-09 | Boston Scientific Scimed, Inc. | Stent side branch deployment initiation geometry |
DE102005024913A1 (en) | 2005-05-31 | 2006-12-14 | Axetis Ag | Stent for insertion into vessel, comprises specifically applied coating for avoidance of new blockage |
US20060275341A1 (en) | 2005-06-02 | 2006-12-07 | Miv Therapeutics Inc. | Thin foam coating comprising discrete, closed-cell capsules |
US7485140B2 (en) | 2005-06-17 | 2009-02-03 | Boston Scientific Scimed, Inc. | Bifurcation stent assembly |
US7637939B2 (en) | 2005-06-30 | 2009-12-29 | Boston Scientific Scimed, Inc. | Hybrid stent |
US20070038176A1 (en) | 2005-07-05 | 2007-02-15 | Jan Weber | Medical devices with machined layers for controlled communications with underlying regions |
US20070027530A1 (en) | 2005-07-26 | 2007-02-01 | Medtronic Vascular, Inc. | Intraluminal device, catheter assembly, and method of use thereof |
US20070043423A1 (en) | 2005-08-10 | 2007-02-22 | Med Institute Inc. | Intraluminal device with a hollow structure |
US20070050016A1 (en) | 2005-08-29 | 2007-03-01 | Boston Scientific Scimed, Inc. | Stent with expanding side branch geometry |
US20070055352A1 (en) | 2005-09-07 | 2007-03-08 | Wendy Naimark | Stent with pockets for containing a therapeutic agent |
US20070112414A1 (en) | 2005-09-08 | 2007-05-17 | Conor Medsystems, Inc. | System and method for local delivery of antithrombotics |
WO2007033152A2 (en) | 2005-09-12 | 2007-03-22 | Conor Medsystems, Inc. | Composition, system and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility |
EP1764116A1 (en) | 2005-09-16 | 2007-03-21 | Debiotech S.A. | Porous coating process using colloidal particles |
US20070065418A1 (en) | 2005-09-20 | 2007-03-22 | Franco Vallana | Method and device for cellular therapy |
US20070073385A1 (en) | 2005-09-20 | 2007-03-29 | Cook Incorporated | Eluting, implantable medical device |
US7404823B2 (en) | 2005-10-31 | 2008-07-29 | Boston Scientific Scimed, Inc. | Stent configurations |
US20070173787A1 (en) | 2005-11-01 | 2007-07-26 | Huang Mark C T | Thin-film nitinol based drug eluting stent |
US7935379B2 (en) | 2005-11-14 | 2011-05-03 | Boston Scientific Scimed, Inc. | Coated and imprinted medical devices and methods of making the same |
US20070112421A1 (en) | 2005-11-14 | 2007-05-17 | O'brien Barry | Medical device with a grooved surface |
US20070110786A1 (en) | 2005-11-15 | 2007-05-17 | Boston Scientific Scimed, Inc. | Medical articles having enhanced therapeutic agent binding |
CN104013996B (en) | 2005-11-15 | 2018-02-02 | 奥巴斯尼茨医学公司 | The drug eluting implantable medical device of progenitor endothelial cell capturing |
US20070151638A1 (en) | 2005-12-29 | 2007-07-05 | Robert Burgermeister | Method to develop an organized microstructure within an implantable medical device |
US20070173923A1 (en) | 2006-01-20 | 2007-07-26 | Savage Douglas R | Drug reservoir stent |
US20070191816A1 (en) | 2006-02-13 | 2007-08-16 | Boston Scientific Scimed, Inc. | Radio frequency induced drug elution |
US7910152B2 (en) | 2006-02-28 | 2011-03-22 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide)-based drug delivery systems with controlled release rate and morphology |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US7709045B2 (en) | 2006-04-28 | 2010-05-04 | Boston Scientific Scimed, Inc. | Medical devices coated with porous carbon and methods of manufacturing the same |
US20070259116A1 (en) | 2006-05-02 | 2007-11-08 | Boston Scientific Scimed, Inc. | Partially coated workpiece and method of making same |
EP1891988A1 (en) | 2006-08-07 | 2008-02-27 | Debiotech S.A. | Anisotropic nanoporous coatings for medical implants |
US8048168B2 (en) | 2006-06-16 | 2011-11-01 | Boston Scientific Scimed, Inc. | Partially soluble implantable or insertable medical devices |
US8016879B2 (en) | 2006-08-01 | 2011-09-13 | Abbott Cardiovascular Systems Inc. | Drug delivery after biodegradation of the stent scaffolding |
DE102006038241A1 (en) | 2006-08-07 | 2008-02-14 | Biotronik Vi Patent Ag | Stent with a genisteinhaltigen coating or Kavitätenfüllung |
EP1891995A1 (en) | 2006-08-08 | 2008-02-27 | Debiotech S.A. | Drug loading of porous coating |
US9248121B2 (en) | 2006-08-21 | 2016-02-02 | Abbott Laboratories | Medical devices for controlled drug release |
US20080051881A1 (en) | 2006-08-24 | 2008-02-28 | Feng James Q | Medical devices comprising porous layers for the release of therapeutic agents |
ATE508708T1 (en) | 2006-09-14 | 2011-05-15 | Boston Scient Ltd | MEDICAL DEVICES WITH A DRUG-RELEASING COATING |
JP2010503490A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Endoprosthesis with adjustable surface features |
ATE517590T1 (en) | 2006-09-15 | 2011-08-15 | Boston Scient Ltd | BIOLOGICALLY ERODABLE ENDOPROTHESES |
CA2663439A1 (en) | 2006-09-18 | 2008-03-27 | Kevin Silberg | Medical device with porous surface |
US20080071349A1 (en) | 2006-09-18 | 2008-03-20 | Boston Scientific Scimed, Inc. | Medical Devices |
US7666179B2 (en) | 2006-10-10 | 2010-02-23 | Boston Scientific Scimed, Inc. | Medical devices having porous regions for controlled therapeutic agent exposure or delivery |
WO2008051342A2 (en) | 2006-10-20 | 2008-05-02 | Boston Scientific Limited | Reduction of burst release from therapeutically treated medical devices |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US20080294236A1 (en) | 2007-05-23 | 2008-11-27 | Boston Scientific Scimed, Inc. | Endoprosthesis with Select Ceramic and Polymer Coatings |
EP1941950A1 (en) | 2006-12-05 | 2008-07-09 | Linde Aktiengesellschaft | Method of fabricating porous surfaces on metal components |
EP2091474B1 (en) | 2006-12-07 | 2010-07-07 | Mallinckrodt Inc. | Medical devices for localized drug delivery |
US8221496B2 (en) | 2007-02-01 | 2012-07-17 | Cordis Corporation | Antithrombotic and anti-restenotic drug eluting stent |
US8187255B2 (en) | 2007-02-02 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US20080208325A1 (en) | 2007-02-27 | 2008-08-28 | Boston Scientific Scimed, Inc. | Medical articles for long term implantation |
US20080275543A1 (en) | 2007-05-02 | 2008-11-06 | Boston Scientific Scimed, Inc. | Stent |
-
2007
- 2007-11-28 US US11/946,632 patent/US7833266B2/en not_active Expired - Fee Related
-
2008
- 2008-11-12 WO PCT/US2008/083248 patent/WO2009070447A1/en active Application Filing
- 2008-11-12 CA CA2705356A patent/CA2705356A1/en not_active Abandoned
- 2008-11-12 CN CN200880118602XA patent/CN101878008A/en active Pending
- 2008-11-12 JP JP2010536049A patent/JP2011504788A/en active Pending
- 2008-11-12 EP EP08854983A patent/EP2224886A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0815806A2 (en) * | 1996-06-27 | 1998-01-07 | Cordis Corporation | Controlled porosity endovascular implant |
US20010029660A1 (en) * | 1997-09-30 | 2001-10-18 | Johnson Michael W. | Stent drug delivery system |
US20050266039A1 (en) * | 2004-05-27 | 2005-12-01 | Jan Weber | Coated medical device and method for making the same |
WO2006098889A2 (en) * | 2005-03-14 | 2006-09-21 | Conor Medsystems, Inc. | Expandable medical device with openings for delivery of multiple beneficial agents |
Also Published As
Publication number | Publication date |
---|---|
EP2224886A1 (en) | 2010-09-08 |
CA2705356A1 (en) | 2009-06-04 |
JP2011504788A (en) | 2011-02-17 |
US7833266B2 (en) | 2010-11-16 |
CN101878008A (en) | 2010-11-03 |
US20090138075A1 (en) | 2009-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2043567B1 (en) | Stent design with variable expansion columns along circumference | |
US7959669B2 (en) | Bifurcated stent with open ended side branch support | |
US20080275543A1 (en) | Stent | |
US8663313B2 (en) | Low strain high strength stent | |
US8414637B2 (en) | Stent | |
US7833266B2 (en) | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment | |
EP1933776B1 (en) | Crown stent assembly | |
EP2658485B1 (en) | Stent | |
US7537608B2 (en) | Stent with variable crimping diameter | |
US8298278B2 (en) | Bifurcated stent with improvement securement | |
EP2086475B1 (en) | Bifurcated stent | |
WO2008033176A1 (en) | Hybrid symmetrical stent designs | |
US20070225798A1 (en) | Side branch stent | |
US20070208419A1 (en) | Bifurcation stent with uniform side branch projection | |
US20100010618A1 (en) | Overlapping Stent | |
EP2073766B1 (en) | Bifurcated stent with entire circumferential petal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880118602.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08854983 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2705356 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010536049 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008854983 Country of ref document: EP |